Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Mar. 31, 2018 | May 10, 2018 | |
Document And Entity Information | ||
Entity Registrant Name | Propanc Biopharma, Inc. | |
Entity Central Index Key | 1,517,681 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2018 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --06-30 | |
Entity Filer Category | Smaller Reporting Company | |
Entity Common Stock, Shares Outstanding | 38,324,191 | |
Trading Symbol | PPCB | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2,018 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) | Mar. 31, 2018 | Jun. 30, 2017 |
CURRENT ASSETS: | ||
Cash | $ 9,296 | $ 69,043 |
GST tax receivable | 2,357 | 8,111 |
Prepaid expenses and other current assets | 87,634 | 4,822 |
TOTAL CURRENT ASSETS | 99,287 | 81,976 |
Security deposit - related party | 2,307 | 2,303 |
Property and equipment, net | 9,152 | 10,790 |
TOTAL ASSETS | 110,746 | 95,069 |
CURRENT LIABILITIES: | ||
Accounts payable | 1,209,688 | 483,513 |
Accrued expenses and other payables | 372,181 | 477,347 |
Convertible notes and related accrued interest, net of discounts and premiums | 4,514,921 | 3,479,845 |
Loans payable | 2,303 | |
Embedded conversion option liabilities | 555,166 | 877,403 |
Warrant derivative liability | 3,769 | |
Due to directors - related parties | 34,192 | 35,204 |
Loans from directors and officer - related parties | 56,906 | 56,802 |
Employee benefit liability | 140,606 | 120,634 |
TOTAL CURRENT LIABILITIES | 6,883,660 | 5,536,820 |
Commitments and Contingencies (See Note 7) | ||
STOCKHOLDERS’ DEFICIT: | ||
Common stock, $0.001 par value; 400,000,000 shares authorized; 31,084,610 and 4,578,284 shares issued; 31,060,132 and 4,553,806 outstanding as of March 31, 2018 and June 30, 2017, respectively | 31,084 | 4,578 |
Additional paid-in capital | 37,211,109 | 32,980,420 |
Accumulated other comprehensive loss | (113,379) | (141,749) |
Accumulated deficit | (43,860,251) | (38,243,523) |
Treasury stock | (46,477) | (46,477) |
TOTAL STOCKHOLDERS’ DEFICIT | (6,772,914) | (5,441,751) |
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | 110,746 | 95,069 |
Series A Preferred Stock [Member] | ||
STOCKHOLDERS’ DEFICIT: | ||
Preferred stock value | 5,000 | 5,000 |
Series B Preferred Stock [Member] | ||
STOCKHOLDERS’ DEFICIT: | ||
Preferred stock value |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2018 | Jun. 30, 2017 |
Preferred stock, par value | $ 0.01 | |
Preferred stock, shares authorized | 1,500,005 | |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 400,000,000 | 400,000,000 |
Common stock, shares issued | 31,084,610 | 4,578,284 |
Common stock, shares outstanding | 31,060,132 | 4,553,806 |
Series A Preferred Stock [Member] | ||
Preferred stock, par value | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized | 1,500,000 | 1,500,000 |
Preferred stock, shares issued | 500,000 | 500,000 |
Preferred stock, shares outstanding | 500,000 | 500,000 |
Series B Preferred Stock [Member] | ||
Preferred stock, par value | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized | 5 | 5 |
Preferred stock, shares issued | 1 | 1 |
Preferred stock, shares outstanding | 1 | 1 |
Consolidated Statements of Oper
Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2018 | Mar. 31, 2017 | Mar. 31, 2018 | Mar. 31, 2017 | |
REVENUE | ||||
Revenue | ||||
OPERATING EXPENSES | ||||
Administration expenses | 723,992 | 1,153,138 | 1,750,840 | 3,893,534 |
Occupancy expenses | 8,005 | 7,649 | 23,734 | 22,237 |
Research and development | 75,138 | 386,490 | 1,673,606 | 714,889 |
TOTAL OPERATING EXPENSES | 807,135 | 1,547,277 | 3,448,180 | 4,630,660 |
LOSS FROM OPERATIONS | (807,135) | (1,547,277) | (3,448,180) | (4,630,660) |
OTHER INCOME (EXPENSE) | ||||
Interest expense | (830,911) | (798,361) | (2,210,097) | (2,525,375) |
Interest income | 15 | 648 | 82 | 661 |
Change in fair value of derivative liabilities | 207,736 | 273,545 | (22,035) | 603,938 |
Gain (loss) on debt settlements, net | (71,151) | (343) | (34,337) | (131,900) |
Gain (loss) on extinguishment of debt, net | 240,301 | 156,574 | ||
Foreign currency transaction gain (loss) | (230,346) | 394,503 | (239,498) | 143,169 |
TOTAL OTHER INCOME (EXPENSE) | (684,356) | (130,008) | (2,349,311) | (1,909,507) |
LOSS BEFORE INCOME TAXES | (1,491,491) | (1,677,285) | (5,797,491) | (6,540,167) |
TAX BENEFIT | 485 | 306,159 | 180,763 | 306,159 |
NET LOSS | $ (1,491,006) | $ (1,371,126) | $ (5,616,728) | $ (6,234,008) |
BASIC AND DILUTED NET LOSS PER SHARE | $ (0.06) | $ (0.38) | $ (0.42) | $ (1.86) |
BASIC AND DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING | 23,426,370 | 3,653,154 | 13,247,004 | 3,347,593 |
NET LOSS | $ (1,491,006) | $ (1,371,126) | $ (5,616,728) | $ (6,234,008) |
OTHER COMPREHENSIVE INCOME (LOSS) | ||||
Unrealized foreign currency translation gain (loss) | 198,634 | (473,998) | 28,370 | (217,100) |
TOTAL OTHER COMPREHENSIVE INCOME (LOSS) | 198,634 | (473,998) | 28,370 | (217,100) |
TOTAL COMPREHENSIVE INCOME (LOSS) | $ (1,292,372) | $ (1,845,124) | $ (5,588,358) | $ (6,451,108) |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 9 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net loss | $ (5,616,728) | $ (6,234,008) |
Adjustments to Reconcile Net loss to Net Cash Used in Operating Activities: | ||
Issuance and amortization of common stock for services | 139,845 | 531,958 |
Issuance of convertible promissory notes for services | 310,000 | 500,000 |
Warrant modification expense | 23,495 | |
Loss on settlements | 34,337 | 131,900 |
Foreign currency transaction loss (gain) | 239,498 | (143,169) |
Depreciation expense | 1,684 | 1,628 |
Amortization of debt discount | 628,066 | 1,835,899 |
Change in fair value of derivative liabilities | 22,035 | (603,938) |
Gain on extinguishment of debt | (156,574) | |
Stock option expense | 491,058 | 1,473,174 |
Reduction of put premium due to payment of debt | (80,769) | |
Accretion of put premium | 1,492,516 | 619,436 |
Changes in Assets and Liabilities: | ||
GST receivable | 5,864 | 19,953 |
Prepaid expenses and other assets | (83,305) | |
Prepaid expenses and other assets - related parties | 2,267 | |
Accounts payable | 745,659 | 119,443 |
Accounts payable - related parties | 15,450 | |
Employee benefit liability | 20,076 | 17,682 |
Payment for security deposit | 1,662 | |
Accrued expenses | (76,514) | 190,899 |
Accrued interest | 153,167 | 47,189 |
NET CASH USED IN OPERATING ACTIVITIES | (1,730,085) | (1,449,080) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Loan repayments | (2,345) | |
Proceeds from convertible promissory notes | 2,385,781 | 923,750 |
Repayments of convertible promissory notes | (490,181) | |
Proceeds from the exercise of warrants | 464,286 | |
NET CASH PROVIDED BY FINANCING ACTIVITIES | 1,893,255 | 1,388,036 |
Effect of exchange rate changes on cash | (222,917) | (50,968) |
NET DECREASE IN CASH | (59,747) | (112,012) |
CASH AT BEGINNING OF PERIOD | 69,043 | 121,070 |
CASH AT END OF PERIOD | 9,296 | 9,058 |
Supplemental Disclosure of Cash Flow Information | ||
Interest | 16,899 | |
Income Tax | ||
Supplemental Disclosure of Non-Cash Investing and Financing Activities | ||
Cancellation of shares for convertible note payable | 112,500 | |
Reduction of put premium related to conversions of convertible note | 678,806 | 132,955 |
Conversion of convertible notes and accrued interest to common stock | 2,174,699 | 934,241 |
Discounts related to warrants issued with convertible debenture | 910,178 | |
Discounts related to derivative liability | 510,000 | 650,000 |
Settlement of accounts payable for shares of common stock | $ 50,000 |
Nature of Operations and Summar
Nature of Operations and Summary of Significant Accounting and Reporting Policies | 9 Months Ended |
Mar. 31, 2018 | |
Accounting Policies [Abstract] | |
Nature of Operations and Summary of Significant Accounting and Reporting Policies | NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES Nature of Operations Propanc Biopharma, Inc. (the “Company,” “we,” “us,” “our” or “Propanc Biopharma”) was originally incorporated in Melbourne, Victoria Australia on October 15, 2007 as Propanc PTY LTD, and continues to be based in Camberwell, Victoria Australia. Since its inception, substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. It is currently in the preclinical phase of development. On November 23, 2010, the Company was incorporated in the state of Delaware as Propanc Health Group Corporation. In January 2011, to reorganize the Company, we acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary of the Company. Effective April 20, 2017, the Company changed its name to “Propanc Biopharma, Inc.” to better reflect the Company’s stage of growth and development. The Company has filed six patent applications relating to its lead product, PRP. The first application was filed in October 2010 in each of the countries listed in the table below. This application has been granted and remains in force in the United States, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore and South Africa. In Brazil, Canada, Hong Kong, Malaysia, Mexico and South Korea, the patent application remains under examination. The patent application in the European Union has recently been accepted. In 2016 and 2017 we filed other patent applications, as indicated below. Three applications were filed under the Patent Cooperation Treaty (the “PCT”). The PCT assists applicants in seeking patent protection by filing one international patent application under the PCT, applicants can then seek protection for an invention in over 150 countries. Once national or regional applications are filed, the application is placed under the control of the national or regional patent offices, as applicable, in what is called the national or regional phase. No. Title Country Case Status Date Filed 1. A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic reduction agent. USA, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore and South Africa Granted Oct-22-2010 Brazil, Canada, Hong Kong, India, Malaysia, Mexico, Republic of Korea Under Examination Europe Accepted 2. Proenzyme composition PCT Application filed and pending Nov-11-2016 3. Cancer Treatment PCT Application filed and pending Jan-27-2017 4. Composition of proenzymes for cancer treatment PCT Application filed and pending Apr-12-2017 The Company hopes to capture and protect additional patentable subject matter based on the Company’s field of technology relating to pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product candidate, PRP, through various stages of development. On April 20, 2017, the Company filed a certificate of amendment to its certificate of incorporation whereby the Company (i) decreased the number of authorized shares of common stock, par value $0.001 per share (the “Common Stock”) to 100,000,000 (ii) decreased the number of authorized shares of preferred stock to 1,500,005 and (iii) effected a one-for-two hundred and fifty (1:250) reverse stock split of its issued and outstanding shares of Common Stock. Proportional adjustments for the reverse stock split were made to the Company’s outstanding stock options, warrants and equity incentive plans, including all share and per-share data, for all amounts and periods presented in the unaudited consolidated financial statements. On January 23, 2018, Company filed a certificate of amendment to its certificate of incorporation to increase in the number of authorized shares of the Company’s common stock from 100,000,000 to 400,000,000. Basis of Presentation The interim unaudited consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations for the three and nine months ended March 31, 2018 and 2017 and cash flows for the nine months ended March 31, 2018 and 2017 and our financial position at March 31, 2018 have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year. Reference is frequently made herein to the Financial Accounting Standards Board (the “FASB”) Accounting Standards Codification (“ASC”). This is the source of authoritative US GAAP recognized by the FASB to be applied to non-governmental entities. Each ASC reference in this filing is presented with a three-digit number, which represents its Topic. As necessary for explanation and as applicable, an ASC topic may be followed with a two-digit subtopic, a two-digit section or a two-or-three-digit paragraph. Certain information and disclosures normally included in the notes to the annual audited consolidated financial statements have been condensed or omitted from these interim unaudited consolidated financial statements. Accordingly, these interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2017. The June 30, 2017 balance sheet is derived from those statements. Principles of Consolidation The unaudited consolidated financial statements include the accounts of Propanc Biopharma, Inc. and its wholly-owned subsidiary, Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying unaudited consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates. Foreign Currency Translation and Other Comprehensive Income (Loss) The Company’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into United States dollars ($ and/or USD) as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the statement of operations and comprehensive income (loss) as other income (expense). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Other Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses). As of March 31, 2018, and June 30, 2017, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing the unaudited consolidated financial statements were as follows: March 31, 2018 June 30, 2017 Exchange rate on balance sheet dates USD : AUD exchange rate 0.7816 0.7676 Average exchange rate for the period USD : AUD exchange rate 0.7690 0.7544 Changes in Accumulated Other Comprehensive Income (Loss) by Component during the nine months ended March 31, 2018 was as follows: Foreign Currency Items: Beginning balance, June 30, 2017 $ (141,749 ) Foreign currency translation gain 28,370 Ending balance, March 31, 2018 $ (113,379 ) Fair Value of Financial Instruments and Fair Value Measurements The Company measures its financial assets and liabilities in accordance with US GAAP. For certain of the Company’s financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued expenses and other liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for loans payable, also approximate fair value because current interest rates available to us for debt with similar terms and maturities are substantially the same. The Company has adopted ASC 820, “ Fair Value Measurement, Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. The estimated fair value of certain financial instruments, including accounts receivable and accounts payable are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The cost basis of notes and convertible debentures approximates fair value due to the market interest rates carried for these instruments. Also see Note 10 - Derivative Financial Instruments. Cash and Cash Equivalents Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were no cash equivalents as of March 31, 2018 or June 30, 2017. Patents Patents are stated at cost and reclassified to intangible assets and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency. However, the Company will expense any product costs for so long as we remain in the startup stage. Accordingly, as the Company’s products were and are not currently approved for market, all patent costs incurred from 2013 through March 31, 2018 were expensed immediately. This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency. Impairment of Long-Lived Assets In accordance with ASC 360-10, “ Long-lived assets,” Australian Goods and Services Tax (GST) Revenues, expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office. Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows. As of March 31, 2018, and June 30, 2017, the Company was owed $2,357 and $8,111, respectively, from the Australian Taxation Office. These amounts were fully collected subsequent to the balance sheet reporting dates. Derivative Instruments ASC Topic 815, Derivatives and Hedging Convertible Notes With Variable Conversion Options The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, “ Distinguishing Liabilities from Equity Income Taxes The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows ASC 740 “ Accounting for Income Taxes The Company adopted provisions of ASC 740, Sections 25 through 60, “ Accounting for Uncertainty in Income Taxes Research and Development Costs and Tax Credits In accordance with ASC 730-10, “Research and Development-Overall,” The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company’s net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as an income tax benefit, in operations, upon receipt. During the nine months ended March 31, 2018 and 2017, the Company applied for, and received from the Australian Taxation Office, a research and development tax credit in the amount of $180,763 and $306,159 respectively, which is reflected as a tax benefit in the accompanying consolidated statements of operations and comprehensive income (loss). Stock Based Compensation The Company records stock-based compensation in accordance with ASC 718, “ Stock Compensation Share Based Payment The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 “ Equity-Based Payments to Non-Employees Basic and Diluted Net Loss Per Common Share Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. As of March 31, 2018, there were 149,517 warrants outstanding, 572,000 stock options and 18 convertible notes payable, which notes are convertible into 57,448,803 common shares. Such securities are considered dilutive securities which were excluded from the computation since the effect is anti-dilutive. Recently Adopted Accounting Pronouncements Certain FASB Accounting Standard Updates (“ASU”) that are not effective until after March 31, 2018 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations. The Company is evaluating or has implemented the following at March 31, 2018: In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments In February 2016, the FASB issued ASU 2016-02, “Leases,” |
Going Concern
Going Concern | 9 Months Ended |
Mar. 31, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Going Concern | NOTE 2 – GOING CONCERN The accompanying unaudited consolidated financial statements have been prepared in conformity with US GAAP, and contemplate continuation of the Company as a going concern. For the nine months ended March 31, 2018, the Company had no revenues, had a net loss of $5,616,728 and had net cash used in operations of $1,730,085. Additionally, as of March 31, 2018, the Company had a working capital deficit, stockholders’ deficit and accumulated deficit of $6,784,373, $6,772,914 and $43,860,251, respectively. It is management’s opinion that these conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date of this filing. The unaudited consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty. Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company’s patent applications and ultimately achieving a level of sales adequate to support the Company’s cost structure. However, there can be no assurances that the Company will be able to secure additional debt or equity investments or achieve an adequate sales level. |
Due to Directors - Related Part
Due to Directors - Related Parties | 9 Months Ended |
Mar. 31, 2018 | |
Due To Directors - Related Parties | |
Due to Directors - Related Parties | NOTE 3 – DUE TO DIRECTORS - RELATED PARTIES Due to directors - related parties represents unsecured advances made primarily by a former director for operating expenses on behalf of the Company such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company and are due upon demand. The Company is currently not being charged interest under these advances. The total amount owed the former director at March 31, 2018 and June 30, 2017 is $34,192 and $35,204, respectively. The Company repaid $1,077 during the nine months ended March 31, 2018. |
Loans and Notes Payable
Loans and Notes Payable | 9 Months Ended |
Mar. 31, 2018 | |
Loans And Notes Payable | |
Loans and Notes Payable | NOTE 4 – LOANS AND NOTES PAYABLE Loans from Directors and Officer - Related Parties Loans from Directors and Officer at March 31, 2018 and June 30, 2017 were $56,906 and $56,802, respectively. The loans bear no interest and are all payable on demand. The Company did not repay any amount on these loans during the nine months ended March 31, 2018. Other Loans from Unrelated Parties As of March 31, 2018, and June 30, 2017, other loans from unrelated parties had a balance of $0 and $2,303, respectively. The Company repaid these loans outstanding as of June 30, 2017 in full during the nine months ended March 31, 2018. |
Convertible Notes
Convertible Notes | 9 Months Ended |
Mar. 31, 2018 | |
Debt Disclosure [Abstract] | |
Convertible Notes | NOTE 5 – CONVERTIBLE NOTES Convertible notes outstanding at March 31, 2018 were as follows: Convertible notes and debenture $ 3,128,435 Unamortized discounts (446,682 ) Accrued interest 124,394 Premium 1,708,774 Convertible notes, net $ 4,514,921 Delafield Financing Agreements Initial Securities Purchase Agreement On October 28, 2015, the Company entered into a securities purchase agreement with Delafield Investments Limited (the “Purchaser” or “Delafield”), whereby the Purchaser purchased a $4,000,000 5% convertible debenture in the principal amount of $4,350,000. Additionally, Delafield received a warrant to purchase an aggregate of 104,762 shares of the Company’s common stock. As of June 30, 2017, the principal balance of the convertible debenture was $720,271 and the related derivative liability associated with the convertible debenture was $252,303. During the nine months ended March 31, 2018, the Company converted $380,090 in principal and $8,250 in accrued interest into shares of the Company’s common stock (see Note 6). On January 2, 2018, the Company repaid the remaining principal balance of $340,181, the derivative liability was revalued, and the Company recorded $199,339 to gain on debt extinguishment. Additional Debenture On September 13, 2016, the Company entered into an Additional Issuance agreement (“Additional Debenture”) with the Purchaser whereby the Purchaser loaned an additional $150,000 to the Company in exchange for a 5% Original Issue Discount Senior Secured Convertible Debenture of the Company in the principal amount of $165,000. As of June 30, 2017, the Company recorded accrued interest of $8,250 and had a principal balance of $165,000 outstanding. Additional at June 30, 2017, the derivative liability related to the Additional Debenture was $54,727. As of March 31, 2018, all $165,000 in outstanding principal under the Additional Issuance Debenture along with $8,250 of accrued interest was fully converted into shares of the Company’s common stock (see Note 6). December Letter Agreement On December 2, 2016, the Company entered into a Letter Agreement with the Purchaser pursuant to which the parties agreed to cancel warrants to purchase up to 960,000 shares of common stock in exchange for an 8% convertible redeemable promissory note in the principal amount of $150,000. As of June 30, 2017, the Company recorded accrued interest of $6,937 and had a principal balance of $150,000 outstanding. On January 2, 2018, the Company repaid the remaining principal balance of $150,000 and accrued interest of $16,899. Eagle Equities Finance Agreements December 12, 2016 Securities Purchase Agreement On December 12, 2016, the Company entered into a Securities Purchase Agreement, with Eagle Equities, pursuant to which Eagle Equities purchased two 8% convertible redeemable junior subordinated promissory notes, each in the principal amount of $100,000. The first note (the “December 12 Note”) was funded with cash and the second note (the “December 12 Eagle Back-End Note”) was initially paid for by an offsetting promissory note issued by Eagle Equities to the Company (the “December 12 Note Receivable”). The terms of the December 12 Eagle Back-End Note require cash funding prior to any conversion thereunder. The December 12 Note Receivable is due December 12, 2017, unless certain conditions are not met, in which case both the December 12 Eagle Back-End Note and the December 12 Note Receivable may both be cancelled. Both the December 12 Note and the December 12 Eagle Back-End Note have a maturity date one year from the date of issuance upon which any outstanding principal and interest is due and payable. The outstanding principal amounts plus accrued interest under both the December 12 Note and the December 12 Eagle Back-End Note are convertible into the Company’s common stock at a conversion price equal to 60% of the lowest closing bid price of the common stock for the ten trading days prior to the conversion, subject to adjustment in certain events. On April 11, 2017, the Company received payment of the December 12 Note Receivable in the amount of $100,000 that offset the December Eagle Back-End Note. Proceeds from the Note Receivable of $5,000 were paid directly to legal fees resulting in net cash proceeds of $95,000 received by the Company. As a result, the December 12 Eagle Back-End Note is now convertible. The December 12 Note and the December 12 Eagle Back-End Note are treated as stock settled debt under ASC 480 and accordingly the Company recorded a put premium of $66,667 as each of the notes were funded. As of March 31, 2018, the outstanding principal under the December 12 Note along with $8,296 of accrued interest was fully converted into shares of the Company’s common stock (see Note 6) and the repayment resulted in a full reduction of the put premium. The Company has recorded $7,781 of accrued interest on the December 12 Eagle Back-End Note as of March 31, 2018 and total principal outstanding on the December 12 Eagle Back-End Note as of March 31, 2018 was $100,000. The December 12 Eagle Back-End Note matured on December 12, 2017. The Company is currently in discussions with Eagle Equities to extend the maturity date. Neither the December 12 Note nor the Eagle Back-End Note may be prepaid. Upon an event of default, principal and accrued interest will become immediately due and payable under the notes. Additionally, upon an event of default, both notes will accrue interest at a default interest rate of 24% per annum or the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions. December 21, 2016 Securities Purchase Agreement On December 21, 2016, the Company entered into a Securities Purchase Agreement with Eagle Equities pursuant to which Eagle Equities purchased two 8% convertible redeemable junior subordinated promissory notes, each in the principal amount of $157,500. The first note (the “December 21 Note”) was funded with cash and the second note (the “December 21 Eagle Back-End Note”) was initially paid for by an offsetting promissory note issued by Eagle Equities to the Company (the “December 21 Note Receivable”). The terms of the December 21 Eagle Back-End Note require cash funding prior to any conversion thereunder. The December 21 Note Receivable is due December 21, 2017, unless certain conditions are not met, in which case both the December 21 Eagle Back-End Note and the December 21 Note Receivable may both be cancelled. Both the December 21 Note and the December 21 Eagle Back-End Note have a maturity date one year from the date of issuance upon which any outstanding principal and interest is due and payable. The outstanding principal amounts plus accrued interest under both the December 21 and the December 21 Eagle Back-End Note are convertible into common stock at a conversion price equal to 60% of the lowest closing bid price of the common stock for the ten trading days prior to the conversion, subject to adjustment in certain events. On May 4, 2017, the Company received payment of the December 21 Note Receivable in the amount of $157,500 that offset the December 21 Eagle Back-End Note. Proceeds from the Note Receivable of $7,500 were paid directly to legal fees resulting in net cash proceeds of $150,000 received by the Company. As a result, the December 21 Back-End Note is now convertible. The December 21 Note and the December 21 Eagle Back-End Note are treated as stock settled debt under ASC 480 and accordingly the Company recorded a put premium of $105,000 as each of the notes were funded. As of March 31, 2018, the outstanding principal under the December 21 Note and the December 21 Back-End Note along with $7,773 and $5,656, respectively, of accrued interest was fully converted (see Note 6) and the repayments resulted in a full reduction of the put premiums. January 27, 2017 Securities Purchase Agreement On January 27, 2017, the Company entered into a Securities Purchase Agreement with Eagle Equities, LLC, pursuant to which Eagle Equities purchased two 8% convertible redeemable junior subordinated promissory notes, each in the principal amount of $230,000. The first note (the “January 2017 Eagle Note”) was funded with cash and the second note (the “January 2017 Eagle Back-End Note”) was initially paid for by an offsetting promissory note issued by Eagle Equities to the Company (the “January 2017 Eagle Note Receivable”). The terms of the January 2017 Eagle Back-End Note require cash funding prior to any conversion thereunder. The January 2017 Eagle Note Receivable is due September 27, 2017, unless certain conditions are not met, in which case both the January 2017 Eagle Back-End Note and the January 2017 Eagle Note Receivable may both be cancelled. Both the January 2017 Eagle Note and the January 2017 Eagle Back-End Note have a maturity date one year from the date of issuance upon which any outstanding principal and interest is due and payable. The outstanding principal amounts plus accrued interest under both the January 2017 Eagle Note and the January 2017 Eagle Back-End Note are convertible into common stock of the Company at a conversion price equal to 60% of the lowest closing bid price of the common stock for the ten trading days prior to the conversion, subject to adjustment in certain events. On May 4, 2017, the Company received a partial payment of the January 2017 Note Receivable in the amount of $40,000 and on June 3, 2017 the balance of $190,000 was funded, of which $11,250 was paid directly to legal fees. As a result, the January 2017 Eagle Back-End Note is now convertible. The January 2017 Eagle Note and the January 2017 Eagle Back-End Note are treated as stock settled debt under ASC 480 and accordingly the Company is recording a put premium of $153,333 as each of the notes were funded. As of March 31, 2018, the outstanding principal under the January 2017 Eagle Note along with $14,988 of accrued interest was fully converted (see Note 6) and the repayment resulted in a full reduction of the put premium. The Company has recorded $15,487 of accrued interest as of March 31, 2018 for the January 2017 Eagle Back-End and total principal outstanding under the January 2017 Eagle Back-End Note as of March 31, 2018 was $230,000. The January 2017 Eagle Back-End Note matured on January 27, 2018. The Company is currently in discussions with Eagle Equities to extend the maturity date. Neither the January Note nor the January 2017 Eagle Back-End Note may be prepaid. Upon an event of default, principal and accrued interest will become immediately due and payable under the notes. Additionally, upon an event of default, both notes will accrue interest at a default interest rate of 24% per annum or the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions. March 1, 2017 Securities Purchase Agreement On March 1, 2017, the Company entered into a Securities Purchase Agreement with Eagle Equities, pursuant to which Eagle Equities purchased two 8% convertible redeemable junior subordinated promissory notes, each in the principal amount of $220,500. The first note (the “March 2017 Note”) was funded with cash and the second note (the “March 2017 Eagle Back-End Note”) was initially paid for by an offsetting promissory note issued by Eagle Equities to the Company (the “March 2017 Note Receivable”). The terms of the March 2017 Eagle Back-End Note require cash funding prior to any conversion thereunder. Both the March 2017 Note and the March 2017 Eagle Back-End Note have a maturity date of March 1, 2018, upon which any outstanding principal and interest is due and payable. The outstanding principal amounts plus accrued interest under both the March 2017 Note and the March 2017 Eagle Back-End Note are convertible into common stock, of the Company at a conversion price equal to 60% of the lowest closing bid price of the common stock for the ten trading days prior to the conversion, subject to adjustment in certain events. On July 5, 2017, the Company received payment of the March 2017 Note Receivable in the amount of $220,500 that offset the March 2017 Eagle Back-End Note. Proceeds from the Note Receivable of $10,500 were paid directly to legal fees resulting in net cash proceeds of $210,000 received by the Company. As a result, the March 2017 Eagle Back-End Note is now convertible. The March 2017 Note and the March 2017 Eagle Back-End Note are treated as stock settled debt under ASC 480 and accordingly the Company recorded a put premium of $147,000 as each of the notes were funded. The Company has recorded $14,616 of accrued interest as of March 31, 2018 for the March 2017 Note and total principal outstanding as of March 31, 2018 under the March 2017 Note was $168,500 as $52,000 was converted during the nine months ended March 31, 2018 (see Note 6). The Company has recorded $13,049 of accrued interest as of March 31, 2018 for the March 2017 Eagle Back-End Note and total principal outstanding as of March 31, 2018 under the March 2017 Eagle Back-End Note was $220,500. Both the March 2017 Eagle Note and the March 2017 Eagle Back-End Note matured on March 1, 2018. The Company is currently in discussions with Eagle Equities to extend the maturity dates. Neither the March 2017 Note nor the March 2017 Eagle Back-End Note may be prepaid. Upon an event of default, principal and accrued interest will become immediately due and payable under the notes. Additionally, upon an event of default, both notes will accrue interest at a default interest rate of 24% per annum or the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions. August 9, 2017 Securities Purchase Agreement On August 9, 2017, the Company entered into a Securities Purchase Agreement dated as of August 8, 2017, with Eagle Equities, LLC, pursuant to which Eagle Equities purchased two 8% convertible redeemable junior subordinated promissory notes, each in the principal amount of $200,000. The first note (the “August 2017 Note”) was funded with cash and the second note (the “August 2017 Eagle Back-End Note”) was initially paid for by an offsetting promissory note issued by Eagle Equities to the Company (the “August 2017 Note Receivable”). The terms of the August 2017 Eagle Back-End Note require cash funding prior to any conversion thereunder. The August 2017 Note Receivable is due August 8, 2018, unless certain conditions are not met, in which case both the August 2017 Eagle Back-End Note and the August 2017 Note Receivable may both be cancelled. Both the August 2017 Note and the August 2017 Eagle Back-End Note have a maturity date one year from the date of issuance upon which any outstanding principal and interest is due and payable. The outstanding principal amounts plus accrued interest under both the August 2017 Note and the August 2017 Eagle Back-End Note are convertible into common stock of the Company at a conversion price equal to 60% of the lowest closing bid price of the common stock for the ten trading days prior to the conversion, subject to adjustment in certain events. On September 14, 2017, the Company received payment of the August 2017 Note Receivable in the amount of $200,000 that offset the August 2017 Eagle Back-End Note. Proceeds from the August 2017 Note Receivable of $10,000 were paid directly to legal fees resulting in net cash proceeds of $190,000 received by the Company. As a result, the August 2017 Eagle Back-End Note is now convertible. The August 2017 Note and the August 2017 Eagle Back-End Note are treated as stock settled debt under ASC 480 and accordingly the Company recorded a put premium of $133,333 as each of the notes were funded. The Company has recorded $8,147 of accrued interest as of March 31, 2018 for the August 2017 Note and total principal outstanding as of March 31, 2018 under the August 2017 Note was $150,000 as $50,000 was converted during the nine months ended March 31, 2018 (see Note 6). The Company has recorded $8,732 of accrued interest as of March 31, 2018 for the August 2017 Eagle Back-End Note and total principal outstanding as of March 31, 2018 under the August 2017 Eagle Back-End Note was $200,000. The August 2017 Note may be prepaid with certain penalties within 180 days of issuance. The August 2017 Back-End Note may not be prepaid. Upon an event of default, principal and accrued interest will become immediately due and payable under the notes. Additionally, upon an event of default, both notes will accrue interest at a default interest rate of 24% per annum or the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions. October 25, 2017 Securities Purchase Agreement On November 3, 2017, the Company entered into a Securities Purchase Agreement dated as of October 25, 2017, with Eagle Equities, pursuant to which Eagle Equities purchased two 8% convertible redeemable junior subordinated promissory notes, each in the principal amount of $200,000. The first note (the “October 2017 Note”) was funded with cash and the second note (the “October 2017 Eagle Back-End Note”) was initially paid for by an offsetting promissory note issued by Eagle Equities to the Company (the “October 2017 Note Receivable”). The terms of the October 2017 Eagle Back-End Note require cash funding prior to any conversion thereunder. The October 2017 Note Receivable is due June 25, 2018, unless certain conditions are not met, in which case both the October 2017 Eagle Back-End Note and the October 2017 Note Receivable may both be cancelled. Both the October 2017 Note and the October 2017 Eagle Back-End Note have a maturity date one year from the date of issuance upon which any outstanding principal and interest is due and payable. The amounts cash funded plus accrued interest under both the October 2017 Note and the October 2017 Eagle Back-End Note are convertible into common stock, par value $0.001 (the “Common Stock”), of the Company at a conversion price equal to 60% of the lowest closing bid price of the Common Stock for the ten trading days prior to the conversion, subject to adjustment in certain events. On December 6, 2017, the Company received payment of the October 2017 Note Receivable in the amount of $200,000 that offset the October 2017 Eagle Back-End Note. Proceeds from the October 2017 Note Receivable of $10,000 were paid directly to legal fees resulting in net cash proceeds of $190,000 received by the Company. As a result, the October 2017 Eagle Back-End Note is now convertible. The October 2017 Note and the October 2017 Eagle Back-End Note are treated as stock settled debt under ASC 480 and accordingly the Company recorded a put premium of $133,333 as each of the notes were funded. The Company has recorded $6,619 of accrued interest as of March 31, 2018 for the October 2017 Note and total principal outstanding as of March 31, 2018 under the October 2017 Note was $200,000. The Company has recorded $5,085 of accrued interest as of March 31, 2018 for the October 2017 Eagle Back-End Note and total principal outstanding as of March 31, 2018 under the October 2017 Eagle Back-End Note was $200,000. The October 2017 Note may be prepaid with certain penalties within 180 days of issuance. The October 2017 Eagle Back-End Note may not be prepaid. Upon an event of default, principal and accrued interest will become immediately due and payable under the notes. Additionally, upon an event of default, both notes will accrue interest at a default interest rate of 24% per annum or the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions. December 29, 2017 Securities Purchase Agreement The Company entered into an executory contract on December 29, 2017, whereby the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased a convertible promissory note (the “December 2017 Eagle Note”) from the Company in the aggregate principal amount of $532,435, such principal and the interest thereon convertible into shares of the Company’s common stock at the option of Eagle Equities at any time. The transactions closed on January 2, 2018. The December 2017 Eagle Note contains an original issue discount of $25,354 such that the purchase price is $507,081. The maturity date of the December 2017 Eagle Note is December 29, 2018. The December 2017 Eagle Note shall bear interest at a rate of 8% per annum, which interest shall be paid by the Company to Eagle Equities in shares of common stock upon receipt of a notice of conversion by the Company from Eagle Equities at any time. The Company has recorded $10,386 of accrued interest as of March 31, 2018 for the December 2017 Eagle Note and total principal outstanding as of March 31, 2018 under the December 2017 Eagle Note was $532,435. Additionally, Eagle Equities has the option to convert all or any amount of the principal face amount of the December 2017 Eagle Note, at any time, for shares of the Company’s common stock at a price equal to 60% of the lowest closing bid price of the Company’s common stock as reported on the OTC Markets Group, Inc. quotation system for the ten prior trading days, including the day upon which the Company receives a notice of conversion from Eagle Equities. The note is treated as stock settled debt under ASC 480 and accordingly the Company recorded a $354,956 put premium. The December 2017 Eagle Note may be prepaid with certain penalties until June 27, 2018. The Company used all of the proceeds from the December 2017 Eagle Note to pay off the remainder of its outstanding debt owed to Delafield, an affiliate of Magna Invests, as previously disclosed. The total principal amount outstanding under the above Eagle Equities finance agreements, specifically the December 12, 2016, December 21, 2016, January 27, 2017, the March 1, 2017, the August 9, 2017, October 25, 2017 and the December 29, 2017 agreements was $2,001,435 as of March 31, 2018 and accrued interest totaled $89,893. GS Capital Financing Agreements May 26, 2017 Securities Purchase Agreement On May 26, 2017, the Company entered into a Securities Purchase Agreement with GS Capital Partners, LLC (“GS Capital”), dated as of May 17, 2017, pursuant to which GS Capital purchased an 8% convertible redeemable junior subordinated promissory note in the principal amount of $160,000. The note matures on May 26, 2018, upon which any outstanding principal and interest is due and payable. The note may be prepaid with certain penalties within 180 days of issuance. The amounts funded plus accrued interest are convertible at any time after 180 days into common stock at a conversion price equal to 62% of the lowest closing bid price of the Company’s common stock for the ten trading days prior to the conversion, including the date upon which the conversion notice was received by the Company, subject to adjustment in certain events. The note is treated as stock settled debt under ASC 480 and accordingly the Company recorded a $98,065 put premium. As of March 31, 2018, the outstanding principal under the note along with $7,499 of accrued interest was fully converted (see Note 6) and the repayment resulted in a full reduction of the put premium. July 24, 2017 Securities Purchase Agreement On July 24, 2017, the Company entered into a Securities Purchase Agreement with GS Capital, pursuant to which GS Capital purchased two 8% convertible redeemable junior subordinated promissory notes, each in the principal amount of $160,000. The first note (the “July 2017 GS Note”) was funded with cash and the second note (the “July 2017 GS Back-End Note”) was initially paid for by an offsetting promissory note issued by GS Capital to the Company (the “July 2017 GS Note Receivable”). The terms of the July 2017 GS Back-End Note require cash funding prior to any conversion thereunder. The July 2017 GS Note Receivable is due March 24, 2018, unless certain conditions are not met, in which case both the July 2017 GS Back-End Note and the July 2017 GS Note Receivable may both be cancelled. Both the July 2017 GS Note and the July 2017 GS Back-End Note mature on July 24, 2018 upon which any outstanding principal and interest is due and payable. The amounts cash funded plus accrued interest under both the July 2017 GS Note and the July 2017 GS Back-End Note are convertible into common stock of the Company at a conversion price equal to 62% of the lowest closing bid price of the common stock for the ten trading days prior to the conversion, subject to adjustment in certain events. On January 25, 2018, the Company received payment of the July 2017 GS Note Receivable in the amount of $160,000 that offset the July 2017 GS Back-End Note. Proceeds from the July 2017 GS Note Receivable of $8,000 were paid directly to legal fees resulting in net cash proceeds of $152,000 received by the Company. As a result, the July 2017 GS Back-End Note is now convertible. The July 2017 GS Note and the July 2017 GS Back-End Note are treated as stock settled debt under ASC 480 and accordingly the Company recorded a $98,065 put premium as each of the notes was funded. The Company has recorded $1,405 of accrued interest as of March 31, 2018 for the July 2017 GS Note. Total principal outstanding under the July 2017 GS Note as of March 31, 2018 was $25,000 as $135,000 was converted during the nine months ended March 31, 2018. The Company has recorded $2,279 of accrued interest as of March 31, 2018 for the July 2017 GS Back-End Note. Total principal outstanding under the July 2017 GS Back-End Note as of March 31, 2018 was $160,000. The July 2017 GS Note may be prepaid with certain penalties within 180 days of issuance. The July 2017 GS Back-End Note may not be prepaid. Upon an event of default, principal and accrued interest will become immediately due and payable under the notes. Additionally, upon an event of default, both notes will accrue interest at a default interest rate of 24% per annum or the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions. September 21, 2017 Securities Purchase Agreement On September 21, 2017, the Company entered into Securities Purchase Agreements, with GS Capital, dated as of September 12, 2017, pursuant to which GS Capital purchased two 8% convertible redeemable junior subordinated promissory notes, each in the principal amount of $160,000. The first note (the “September 2017 Note”) was funded with cash and the second note (the “September 2017 Back-End Note”) was initially paid for by an offsetting promissory note issued by GS Capital to the Company (the “September 2017 Note Receivable”). The terms of the September 2017 Back-End Note require cash funding prior to any conversion thereunder. The September 2017 Note Receivable is due March 24, 2018, unless certain conditions are not met, in which case both the September 2017 Back-End Note and the September 2017 Note Receivable may both be cancelled. Both the September 2017 Note and the September 2017 Back-End Note mature on September 12, 2018, upon which any outstanding principal and interest is due and payable. The amounts cash funded plus accrued interest under both the September 2017 Note and the September 2017 Back-End Note are convertible into common stock of the Company at a conversion price equal to 62% of the lowest closing bid price of the common stock for the ten trading days prior to the conversion, subject to adjustment in certain events. On February 27, 2018, the Company received payment of the September 2017 Note Receivable in the amount of $160,000 that offset the September 2017 Back-End Note. Proceeds from the September 2017 Note Receivable of $8,000 were paid directly to legal fees resulting in net cash proceeds of $152,000 received by the Company. As a result, the September 2017 Back-End Note is now convertible. The September 2017 Note and the September 2017 Back-End Note are treated as stock settled debt under ASC 480 and accordingly the Company recorded a $98,065 put premium as each of the notes was funded. The Company has recorded $7,049 of accrued interest as of March 31, 2018 for the September 2017 Note. Total principal outstanding under the September 2017 Note as of March 31, 2018 was $160,000. The Company has recorded $1,122 of accrued interest as of March 31, 2018 for the September 2017 Back-End Note. Total principal outstanding under the September 2017 Back-End Note as of March 31, 2018 was $160,000. The September 2017 Note may be prepaid with certain penalties within 180 days of issuance. The September 2017 Back-End Note may not be prepaid. Upon an event of default, principal and accrued interest will become immediately due and payable under the notes. Additionally, upon an event of default, both notes will accrue interest at a default interest rate of 24% per annum or the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions. March 23, 2018 Securities Purchase Agreement On March 23, 2018, the Company entered into a securities purchase agreement, with GS Capital, pursuant to which GS Capital purchased two 8% convertible redeemable junior subordinated promissory notes, each in the principal amount of $106,000. The first note (the “March 2018 Note”) was funded with cash and the second note (the “March 2018 Back-End Note”) was initially paid for by an offsetting promissory note issued by GS Capital to the Company (the “March 2018 Note Receivable”). The terms of the March 2018 Back-End Note require cash funding prior to any conversion thereunder. The March 2018 Note Receivable is due November 23, 2018, unless certain conditions are not met, in which case both the March 2018 Back-End Note and the March 2018 Note Receivable may both be cancelled. Both the March 2018 Note and the March 2018 Back-End Note mature on March 23, 2019, upon which any outstanding principal and interest is due and payable. The amounts cash funded plus accrued interest under both the March 2018 Note and the March 2018 Back-End Note are convertible into common stock of the Company at a conversion price equal to 62% of the lowest closing bid price of the common stock for the ten trading days prior to the conversion, subject to adjustment in certain events. The March 2018 Note is treated as stock settled debt under ASC 480 and accordingly the Company recorded a $64,968 put premium. The Company has recorded $185 of accrued interest as of March 31, 2018 for the March 2018 Note. Total principal outstanding under the March 2018 Note as of March 31, 2018 was $106,000. The March 2018 Note may be prepaid with certain penalties within 180 days of issuance. The March 2018 Back-End Note may not be prepaid. However, in the event the March 2018 Note is redeemed within the first six months of issuance prior to cash funding of the March 2018 Note Receivable, the March 2018 Back-End Note and the March 2018 Note Receivable will be deemed cancelled and of no further effect. The March 2018 Back-End Note will not be cash funded and such note, along with the March 2018 Note Receivable, will be immediately cancelled if the shares do not maintain a minimum trading price during the five days prior to such funding and a certain aggregate dollar trading volume during such period. Upon an event of default, principal and accrued interest will become immediately due and payable under the notes. Additionally, upon an event of default, both notes will accrue interest at a default interest rate of 24% per annum or the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions. The total principal amount outstanding under the above GS Capital finance agreements, specifically the May 26, 2017, July 24, 2017, September 21, 2017 and the March 23, 2018 agreements, was $611,000 as of March 31, 2018 and accrued interest totaled $12,041. Regal Consulting Agreements November 2016 Consulting Agreement On November 18, 2016 (the “Effective Date”), the Company entered into a consulting agreement with Regal Consulting, LLC (the “Consultant”) for strategic and business advisory services. As compensation for services rendered, the Company issued two fully earned $250,000 convertible junior subordinated promissory notes. Both notes have a two year maturity date and interest of 10% per annum. Both notes are junior and subordinate in all re |
Stockholders' Deficit
Stockholders' Deficit | 9 Months Ended |
Mar. 31, 2018 | |
Equity [Abstract] | |
Stockholders' Deficit | NOTE 6 – STOCKHOLDERS’ DEFICIT Preferred Stock: The total number of preferred shares authorized and that may be issued by the Company is 1,500,005 preferred shares with a par value of $0.01. These preferred shares have no rights to dividends, profit sharing or liquidation preferences. Of the total preferred shares authorized, pursuant to the Certificate of Designation filed on December 9, 2014, 1,500,000 have been designated as Series A preferred stock, with a par value of $0.01 (“Series A Preferred Stock”), of which 500,000 are issued and outstanding as of March 31, 2018. Each holder of outstanding shares of Series A Preferred Stock shall be entitled to voting power equivalent to two shares of Common stock for each share of Series A Preferred Stock held and entitled to vote on all matters, except election or removal of directors of the Company, submitted to a vote of the stockholders of the Company. Of the total preferred shares authorized, pursuant to the Certificate of Designation filed on June 16, 2015, up to five shares have been designated as Series B preferred stock, with a par value of $0.01 (“Series B Preferred Stock”) and 1 share is issued and outstanding at March 31, 2018. Each holder of outstanding shares of Series B Preferred Stock shall be entitled to voting power equivalent to the number of votes equal to the total number of shares of common stock outstanding as of the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company and entitled to vote on all matters submitted or required to be submitted to a vote of the stockholders of the Company. Common Stock: Shares issued for services On August 1, 2017, the Company received an invoice for $30,000 from a third party for six months of consulting services during the period of February 1, 2017 through July 31, 2017. The invoice is payable in shares of the Company’s common stock. The Company has recorded $25,000 in consulting fees related to this invoice for the year ended June 30, 2017 and the balance was recorded in the nine months ended March 31, 2018. On February 15, 2018, the Company issued 234,375 shares and an additional loss on settlement of debt was recorded of $68,438 based on the fair market value on July 31, 2017, when the shares were fully earned, of $0.42. On May 10, 2017, the Company entered into a seven-month agreement from May 10, 2017 through January 10, 2018, excluding August 2017, with a third party for growth strategy consulting services whereby the Company would issue and deliver to the third party, 7,500 shares of common stock per month as consideration for services. Shares will be valued on the 10 th On February 1, 2018, the Company received an invoice for $30,000 from a third party for six months of consulting services during the period of August 1, 2017 through January 31, 2018. The invoice is payable in shares of the Company’s common stock. The Company issued 234,375 shares on February 15, 2018 and recorded $30,000 in consulting fees during the nine months ended March 31, 2018. An additional loss on settlement of debt was recorded of $2,813 based on the fair market value on January 31, 2018, when the shares were fully earned, of $0.14. On December 29, 2017, the Company entered into a one-year consulting agreement with a consultant (the “Consultant”) for certain consulting, advisory and media services. As compensation for such services, the Company agreed to pay (i) an hourly fee of $950 per hour, for up to $71,250 of time-based services; (ii) $9,772 for the preparation of certain marketing materials; (iii) an upfront fee of 500,000 restricted shares of the Company’s common stock, with up to 750,000 additional shares to be issued on the six month anniversary of the date of the consulting agreement at the Company’s sole discretion, and (iv) a marketing bonus equal to 6% of the value of any: (x) business collaboration with the Company which is identified or introduced by the Consultant; or (y) joint venture, licensing, collaboration or similar monetization or strategic transaction (other than any capital-raising transaction) which is identified or introduced by the Consultant. The Company may, in its sole discretion, pay any of the aforementioned fees in cash or shares of the Company’s common stock. If such fees are paid in stock, the number of shares to be paid shall be calculated by dividing the dollar amount of time (or value of the transaction, as the case may be) invoiced in such pay period by, as of the applicable calculation date, the most recent price at which the Company has sold shares of its common stock (or securities convertible into common stock) in a bona fide public or private financing including third party investors. The Company valued the 500,000 shares based on the market price on the agreement date of $0.14 and will recognize $70,000 of consulting expense through the term of the agreement. For the nine months ended March 31, 2018, the Company has recorded $17,835 of expense related to this agreement. On February 15, 2018, the Company issued the 500,000 shares to the Consultant. During the nine months ended March 31, 2018, The Company issued 130,000 shares of common stock that was recorded as issuable at June 30, 2017. Shares issued for conversion of convertible debt On July 5, 2017, pursuant to a conversion notice, $26,000 of principal and $1,121 of interest was converted at $0.54 into 49,946 shares of common stock. On July 13, 2017, pursuant to a conversion notice, $42,500 of principal was converted at $0.63 into 67,694 shares of common stock. On July 17, 2017, pursuant to a conversion notice, $16,000 of principal and $732 of interest was converted at $0.40 into 41,623 shares of common stock. On July 20, 2017, pursuant to a conversion notice, $28,000 of principal and $1,300 of interest was converted at $0.29 into 101,738 shares of common stock. On July 28, 2017, pursuant to a conversion notice, $22,500 in principal and $1,593 in interest was converted at $0.26 into 93,365 shares of common stock. On August 2, 2017, pursuant to a conversion notice, $20,000 of principal was converted at $0.28 into 70,897 shares of common stock. On August 2, 2017, pursuant to a conversion notice, $25,000 of principal and $1,233 of interest was converted at $0.21 into 124,921 shares of common stock. On August 16, 2017, pursuant to a conversion notice, $25,000 of principal and $1,311 of interest was converted at $0.23 into 112,441 shares of common stock. On August 17, 2017, pursuant to a conversion notice, $20,000 of principal was converted at $0.30 into 66,171 shares of common stock. On August 22, 2017, pursuant to a conversion notice, $20,000 of principal and $1,500 of interest was converted at $0.25 into 84,812 shares of common stock. On August 25, 2017, pursuant to a conversion notice, $25,000 of principal and $1,361 of interest was converted at $0.23 into 112,654 shares of common stock. On August 29, 2017, pursuant to a conversion notice, $20,000 of principal was converted at $0.24 into 81,926 shares of common stock. On September 3, 2017, pursuant to a conversion notice, $20,000 of principal and $1,661 of interest was converted at $0.20 into 106,390 shares of common stock. On September 6, 2017, pursuant to a conversion notice, $12,500 of principal and $714 of interest was converted at $0.19 into 71,042 shares of common stock. On September 8, 2017, pursuant to a conversion notice, $20,000 of principal was converted at $0.24 into 83,247 shares of common stock. On September 14, 2017, pursuant to a conversion notice, $15,000 of principal and $450 of interest was converted at $0.15 into 103,000 shares of common stock. On September 14, 2017, pursuant to a conversion notice, $20,000 of principal and $1,665 of interest was converted at $0.16 into 138,878 shares of common stock. On September 18, 2017, pursuant to a conversion notice, $20,000 of principal was converted at $0.19 into 107,527 shares of common stock. On September 25, 2017, pursuant to a conversion notice, $20,000 of principal and $649 of interest was converted at $0.14 into 149,630 shares of common stock. On September 26, 2017, pursuant to a conversion notice, $30,000 of principal was converted at $0.18 into 168,303 shares of common stock. On September 26, 2017, pursuant to a conversion notice, $20,000 of principal and $1,716 of interest was converted at $0.15 into 145,257 shares of common stock. On October 2, 2017, pursuant to a conversion notice, $25,000 of principal and $850 of interest was converted at $0.14 into 187,319 shares of common stock. On October 4, 2017, pursuant to a conversion notice, $40,000 of principal was converted at $0.18 into 224,404 shares of common stock. On October 5, 2017, pursuant to a conversion notice, $20,000 of principal and $1,716 of interest was converted at $0.15 into 145,257 shares of common stock. On October 9, 2017, pursuant to a conversion notice, $30,000 of principal and $1,067 of interest was converted at $0.14 into 215,651 shares of common stock. On October 10, 2017, pursuant to a conversion notice, $45,000 of principal was converted at $0.19 into 241,835 shares of common stock. On October 11, 2017, pursuant to a conversion notice, $20,000 of principal and $1,812 of interest was converted at $0.16 into 139,762 shares of common stock. On October 16, 2017, pursuant to a conversion notice, $20,000 of principal and $1,834 of interest was converted at $0.16 into 134,363 shares of common stock. On October 18, 2017, pursuant to a conversion notice, $25,000 of principal and $939 of interest was converted at $0.13 into 196,507 shares of common stock. On October 19, 2017, pursuant to a conversion notice, $30,000 of principal was converted at $0.16 into 193,549 shares of common stock. On October 23, 2017, pursuant to a conversion notice, $20,000 of principal and $1,884 of interest was converted at $0.11 into 198,045 shares of common stock. On October 24, 2017, pursuant to a conversion notice, $21,000 of principal and $817 of interest was converted at $0.11 into 202,006 shares of common stock. On October 27, 2017, pursuant to a conversion notice, $15,000 of principal was converted at $0.09 into 159,958 shares of common stock. On October 30, 2017, pursuant to a conversion notice, $8,750 of principal and $352 of interest was converted at $0.07 into 144,475 shares of common stock. On October 30, 2017, pursuant to a conversion notice, $20,000 of principal and $1,902 of interest was converted at $0.07 into 300,851 shares of common stock. On November 2, 2017, pursuant to a conversion notice, $5,000 of principal and $8,250 of interest was converted at $0.09 into 155,426 shares of common stock. On November 6, 2017, pursuant to a conversion notice, $12,750 of principal and $533 of interest was converted at $0.05 into 245,158 shares of common stock. On November 6, 2017, pursuant to a conversion notice, $17,500 of principal was converted at $0.07 into 250,897 shares of common stock. On November 8, 2017, pursuant to a conversion notice, $20,000 in principal and $2,356 in interest was converted at $0.06 into 382,153 shares of common stock. On November 13, 2017 pursuant to a conversion notice, $11,000 in principal and $623 in interest was converted at $0.05 into 215,247 shares of common stock. On November 15, 2017 pursuant to a conversion notice, $20,000 in principal and $2,443 in interest was converted at $0.06 into 383,641 shares of common stock. On November 17, 2017 pursuant to a conversion notice, $15,000 in principal was converted at $0.07 into 215,054 shares of common stock. On November 26, 2017 pursuant to a conversion notice, $20,000 in principal and $2,568 in interest was converted at $0.06 into 385,777 shares of common stock. On November 27, 2017 pursuant to a conversion notice, $20,000 in principal and $1,196 in interest was converted at $0.05 into 392,510 shares of common stock. On December 1, 2017 pursuant to a conversion notice, $20,000 in principal and $802 in interest was converted at $0.06 into 372,799 shares of common stock. On December 6, 2017 pursuant to a conversion notice, $21,000 in principal and $1,297 in interest was converted at $0.05 into 412,914 shares of common stock. On December 8, 2017 pursuant to a conversion notice, $9,900 in principal and $792 in interest was converted at $0.05 into 198,000 shares of common stock. On December 8, 2017 pursuant to a conversion notice, $42,666 in principal was converted at $0.07 into 611,699 shares of common stock. On December 11, 2017 pursuant to a conversion notice, $9,900 in principal and $799 in interest was converted at $0.05 into 198,122 shares of common stock. On December 11, 2017 pursuant to a conversion notice, $27,000 in principal and $1,142 in interest was converted at $0.06 into 504,339 shares of common stock. On December 11, 2017 pursuant to a conversion notice, $42,666 in principal was converted at $0.07 into 611,699 shares of common stock. On December 15, 2017 pursuant to a conversion notice, $56,758 in principal was converted at $0.08 into 732,362 shares of common stock. On December 18, 2017 pursuant to a conversion notice, $30,000 in principal and $2,467 in interest was converted at $0.07 into 478,859 shares of common stock. On December 19, 2017 pursuant to a conversion notice, $23,000 in principal and $1,013 in interest was converted at $0.07 into 368,867 shares of common stock. On December 21, 2017 pursuant to a conversion notice, $63,000 in principal was converted at $0.08 into 789,227 shares of common stock. On December 22, 2017 pursuant to a conversion notice, $25,000 in principal and $2,078 in interest was converted at $0.06 into 429,806 shares of common stock. On January 2, 2018 pursuant to a conversion notice, $25,000 in principal and $1,178 in interest was converted at $0.07 into 402,121 shares of common stock. On January 3, 2018 pursuant to a conversion notice, $25,200 in principal and $2,162 in interest was converted at $0.06 into 434,311 shares of common stock. On January 4, 2018 pursuant to a conversion notice, $25,000 in principal and $1,372 in interest was converted at $0.07 into 398,854 shares of common stock. On January 9, 2018 pursuant to a conversion notice, $40,000 in principal and $4,581 in interest was converted at $0.07 into 630,384 shares of common stock. On January 12, 2018 pursuant to a conversion notice, $25,000 in principal and $1,233 in interest was converted at $0.08 into 345,396 shares of common stock. On January 12, 2018 pursuant to a conversion notice, $7,500 in principal and $875 in interest was converted at $0.07 into 116,000 shares of common stock. On January 26, 2018 pursuant to a conversion notice, $30,000 in principal and $1,793 in interest was converted at $0.09 into 353,259 shares of common stock. On January 30, 2018 pursuant to a conversion notice, $40,000 in principal and $2,130 in interest was converted at $0.09 into 492,407 shares of common stock. On February 4, 2018 pursuant to a conversion notice, $22,500 in principal and $2,650 in interest was converted at $0.08 into 314,571 shares of common stock. On February 13, 2018 pursuant to a conversion notice, $20,000 in principal and $1,276 in interest was converted at $0.07 into 285,962 shares of common stock. On February 21, 2018 pursuant to a conversion notice, $40,000 in principal and $4,986 in interest was converted at $0.08 into 571,977 shares of common stock. On February 23, 2018 pursuant to a conversion notice, $25,000 in principal and $1,173 in interest was converted at $0.07 into 351,782 shares of common stock. On February 23, 2018 pursuant to a conversion notice, $20,000 in principal and $1,320 in interest was converted at $0.07 into 296,111 shares of common stock. On February 28, 2018 pursuant to a conversion notice, $60,000 in principal and $4,027 in interest was converted at $0.06 into 1,011,480 shares of common stock. On March 4, 2018 pursuant to a conversion notice, $40,000 in principal and $5,012 in interest was converted at $0.06 into 760,980 shares of common stock. On March 5, 2018 pursuant to a conversion notice, $28,000 in principal and $1,375 in interest was converted at $0.06 into 493,526 shares of common stock. On March 8, 2018 pursuant to a conversion notice, $27,000 in principal and $1,343 in interest was converted at $0.06 into 507,945 shares of common stock. On March 8, 2018 pursuant to a conversion notice, $50,000 in principal and $3,444 in interest was converted at $0.05 into 989,712 shares of common stock. On March 11, 2018 pursuant to a conversion notice, $60,000 in principal and $7,906 in interest was converted at $0.06 into 1,173,828 shares of common stock. On March 14, 2018 pursuant to a conversion notice, $25,000 in principal and $1,756 in interest was converted at $0.05 into 495,473 shares of common stock. On March 16, 2018 pursuant to a conversion notice, $28,000 in principal and $1,442 in interest was converted at $0.06 into 527,637 shares of common stock. On March 21, 2018 pursuant to a conversion notice, $50,000 in principal and $2,089 in interest was converted at $0.05 into 964,609 shares of common stock. On March 26, 2018 pursuant to a conversion notice, $27,000 in principal and $1,450 in interest was converted at $0.06 into 504,251 shares of common stock. The Company has 98,727,377 shares reserved for future issuances based on lender requirements at March 31, 2018. Options: On April 14, 2016 (“Grant Date”), the Board of Directors of the Company, through unanimous written consent, granted 286,000 and 286,000 stock options at an exercise price of $7.50 (market value of the Company’s stock on the Grant Date), to its CEO and to a director, respectively. 95,333 of such stock options vested on April 14, 2016 and expire on April 14, 2021, 95,333 of such stock options shall vest on April 14, 2017 (first anniversary of the Grant Date) and expire on April 14, 2021 and 95,333 of such stock options shall vest on April 14, 2018 (second anniversary of the Grant Date) and expire on April 14, 2021. The fair value of each of the 286,000 options at the Grant Date was $1,962,440 (aggregate total of $3,924,880). The Company expensed $491,058 for these stock options during the nine months ended March 31, 2018. The Company has unrecognized stock option expense of $163,089 as of March 31, 2018. Warrants: As of March 31, 2018, there were 149,517 warrants outstanding and exercisable with expiration dates commencing December 2018 and continuing through November 2020. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Mar. 31, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | NOTE 7 – COMMITMENTS AND CONTINGENCIES Legal Matters From time to time, the Company may be involved in litigation relating to claims arising out of the Company’s operations in the normal course of business. As of March 31, 2018, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company’s operations. IRS Liability As part of its requirement for having a foreign operating subsidiary, the Company is required to file an informational Form 5471 to the Internal Revenue Service (the “IRS”), which is a form that explains the nature of the relationship between the foreign subsidiary and the parent company. From 2012 through the 2014 the Company did not file this form in a timely manner. As a result of the non-timely filings, the Company has incurred a penalty from the IRS in the amount of $10,000 per year, or $30,000, plus accrued interest. The Company recorded the penalties for all three years during the year ended June 30, 2017 and is negotiating a payment plan. The Company is current on all subsequent filings. Operating Agreements In November 2009, the Company entered into a commercialization agreement with the University of Bath (UK) (the “University”) whereby the Company and the University co-owned the intellectual property relating to the Company’s pro-enzyme formulations. In June 2012, the Company and the University entered into an assignment and amendment whereby the Company assumed full ownership of the intellectual property while agreeing to pay royalties of 2% of net revenues to the University. Additionally, the Company agreed to pay 5% of each and every license agreement subscribed for. The contract is cancellable at any time by either party. To date, no amounts are owed under the agreement. Operating Leases On May 4, 2016, the Company entered into a new five-year operating lease agreement with a related party with monthly rent of $3,300 AUD, inclusive of GST (See Note 8). Future minimum operating lease commitments consisted of the following at March 31, 2018: Fiscal Year Ended June 30, Amount (USD) Remainder 2018 $ 7,613 2019 $ 30,452 2020 $ 30,452 2021 $ 25,377 Rent expense for the nine months ended March 31, 2018 and 2017 were $23,734 and $22,237, respectively. Amatsigroup Agreement The Company entered into a Manufacturing Services Agreement (the “MSA”) and Quality Assurance Agreement (the “QAA”), each with an effective date of August 12, 2016, with Amatsigroup NV (“Amatsigroup”), formerly known as Q-Biologicals, NV, a contract manufacturing organization located in Belgium. Pursuant to the MSA, Amatsigroup will produce certain drug substances and product containing certain enzymes at its facility in Belgium. The Company will use these substances and products for development purposes, including but not limited to clinical trials. The MSA contemplates payment to Amatsigroup pursuant to a pre-determined fee schedule based on the completion of certain milestones that depend on our manufacturing requirements and final batch yield. The Company anticipates that its payments to Amatsigroup under the MSA will range between $2.5 million and $5.0 million over five years, with the majority of the expenditures occurring during the first two years of the MSA when the finished drug product is manufactured and released for clinical trials. The Company has incurred $1,557,739 of costs to date under the contract. The MSA shall continue for a term of six years unless extended by mutual agreement in writing. The Company can terminate the MSA early for any reason upon the required notice period, however, in such event, the pre-payment paid upon signing the MSA is considered non-refundable. The QAA sets forth the parties respective obligations and responsibilities relating to the manufacturing and testing of the products under the MSA. The agreements with Amatsigroup contain certain customary representations, warranties and limitations of liabilities, and confidentiality and indemnity obligations. Investment Banking Agreement On February 23, 2018, the Company entered into an agreement with an effective date of February 14, 2018 with an investment bank, (the “Investment Bank”), pursuant to which the Company retained the Investment Bank as its placement agent. The agreement terminates at the close of business on September 30, 2018. As consideration for such services, the Company shall pay the Investment Bank 8% of the total gross proceeds immediately upon closing a successful capital raise placement. Additionally, the Company shall also pay the Investment Bank non-callable warrants for shares of the Company’s common stock equal to 4% of the proceeds raised. The warrants will have a purchase price equal to 110% of the implied price per share of the placement or 110% of the public market closing price of the Company’s common stock on the date of placement, whichever is lower, and will have an exercise period of five years after the closing of the placement. |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Mar. 31, 2018 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | NOTE 8 – RELATED PARTY TRANSACTIONS Since its inception, the Company has conducted transactions with its directors and entities related to such directors. These transactions have included the following: As of March 31, 2018, and June 30, 2017, the Company owed a current and former director a total of $56,906 and $56,802, respectively, for money loaned to the Company throughout the years. The loan balance owed at March 31, 2018 was not interest bearing (See Note 4). As of March 31, 2018, and June 30, 2017, the Company owed its two current directors a total of $34,192 and $35,204, respectively, related to expenses paid on behalf of the Company related to corporate startup costs and intellectual property (See Note 3). Effective May 5, 2016, we entered into an agreement for the lease of our principal executive offices with North Horizon Pty Ltd., of which Mr. Nathanielsz and his wife are owners and directors. The lease has a five year term and provides for annual rental payments of $39,600 AUD, which includes $3,600 of goods and service tax for total payments of $198,000 AUD during the term of the lease. As of March 31, 2018, total payments of $122,100 AUD remain on the lease. Mr. Nathanielsz’s wife, Sylvia Nathanielsz, is and has been an employee of ours since October 2015. Mrs. Nathanielsz received an annual salary of $57,675 through January 31, 2018 and is entitled to customary benefits. Effective February 1, 2018, Mrs. Nathanielsz salary was increased, and she now receives an annual salary of $92,280. Pursuant to a February 25, 2016 board resolution, James Nathanielsz shall be paid $4,481 AUD ($3,502 USD), on a monthly basis for the purpose of acquiring and maintaining an automobile. For the nine months ended March 31, 2018, a total of $31,518 in payments have been made with regards to the board resolution. As per the unanimous written consent of the Board of Directors, on August 15, 2016, James Nathanielsz was granted a $250,000 bonus for accomplishments achieved while serving as the chief executive officer. A total of $130,000 in payments were made in the year ended June 30, 2017. The remaining $120,000 was paid during the nine months ended March 31, 2018. As per the unanimous written consent of the Board of Directors, on March 16, 2018, James Nathanielsz was granted a $300,000 AUD bonus for accomplishments achieved while serving as the chief executive officer. A total of $50,000 was paid during the nine months ended March 31, 2018. The balance of the accrued bonus as of March 31, 2018 is $183,260. |
Concentrations and Risks
Concentrations and Risks | 9 Months Ended |
Mar. 31, 2018 | |
Risks and Uncertainties [Abstract] | |
Concentrations and Risks | NOTE 9 – CONCENTRATIONS AND RISKS Concentration of Credit Risk The Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company has not experienced any losses in such accounts through March 31, 2018. Receivable Concentration As of March 31, 2018 and June 30, 2017, the Company’s receivables were 100% related to reimbursements on GST taxes paid. Patent and Patent Concentration The Company has filed six patent applications relating to its lead product, PRP. The Company’s lead patent application has been granted and remains in force in the United States, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore and South Africa. In Brazil, Canada, Europe, Malaysia, Mexico and South Korea, the patent application remains under examination. In 2016 and early 2017 we filed five other patent applications. Two applications were filed in Spain, where one is currently under examination, and one was filed in the United States. Two others were filed under the Patent Cooperation Treaty (the “PCT”). The PCT assists applicants in seeking patent protection by filing one international patent application under the PCT, applicants can simultaneously seek protection for an invention in over 150 countries. Once filed, the application is placed under the control of the national or regional patent offices, as applicable, in what is called the national phase. Further patent applications are expected to be filed to capture and protect additional patentable subject matter based on the Company’s field of technology relating to pharmaceutical compositions of proenzymes for treating cancer. Foreign Operations As of March 31, 2018, and June 30, 2017, the Company’s operations and subsidiary are based in Australia, however the majority of research and development is being conducted in the European Union. On July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of March 31, 2018, there has been no activity within this entity. |
Derivative Financial Instrument
Derivative Financial Instruments and Fair Value Measurements | 9 Months Ended |
Mar. 31, 2018 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Financial Instruments and Fair Value Measurements | NOTE 10 - DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS Derivative Financial Instruments: The Company applies the provisions of ASC 815-40, Contracts in Entity’s Own Equity The Company calculates the estimated fair values of the liabilities for derivative instruments using the Binomial Trees Method. The closing price of the Company’s common stock at March 31, 2018 was $0.10. Volatility, expected remaining term and risk free interest rates used to estimate the fair value of derivative liabilities at March 31, 2018 are indicated in the table that follows. The volatility was based on historical volatility at March 31, 2018, the expected term is equal to the remaining term of the warrants and the risk free rate is based upon rates for treasury securities with the same term. Warrants March 31, 2018 Volatility 246.60 % Expected remaining term (in years) .5 Risk-free interest rate 1.93 % Expected dividend yield None Convertible Debt Initial Valuations (on new derivative instruments March 31, 2018) March 31, 2018 Volatility 195.25% - 198.43 % 167.81% – 192.32 % Expected Remaining Term (in years) 1 .93 - 1.36 Risk Free Interest Rate 1.79% - 2.06 % 1.87% - 2.09 % Expected dividend yield None None Fair Value Measurements: The Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable warrants and embedded conversion options have been recorded as determined utilizing the Binomial Trees model. The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of March 31 2018: Quoted Prices in Active Significant Markets for Other Significant Balance at March 31, 2018 Identical Assets Observable Inputs Unobservable Inputs (Level 1) (Level 2) (Level 3) Embedded conversion option liabilities $ 555,166 $ — $ — $ 555,166 Total $ 555,166 $ — $ — $ 555,166 The following is a roll forward for the nine months ended March 31, 2018 of the fair value liability of price adjustable derivative instruments: Fair Value of Liability for Derivative Instruments Balance at June 30, 2017 $ 881,172 Effects of foreign currency exchange rate changes 70 Reductions due to conversions (658,772 ) Reductions due to repayment of debt (199,339 ) Initial fair value of embedded conversion option derivative liability recorded as debt discount 510,000 Initial fair value of embedded conversion option derivative liability recorded as change in fair value of embedded conversion option 313,694 Change in fair value included in statements of operations (291,659 ) Balance at March 31, 2018 $ 555,166 |
Subsequent Events
Subsequent Events | 9 Months Ended |
Mar. 31, 2018 | |
Subsequent Events [Abstract] | |
Subsequent Events | NOTE 11 – SUBSEQUENT EVENTS Conversions On April 2, 2018 pursuant to a conversion notice, $50,000 in principal and $2,916 in interest was converted at $0.06 into 912,659 shares of common stock. On April 3, 2018 pursuant to a conversion notice, $25,000 in principal and $1,386 in interest was converted at $0.05 into 506,649 shares of common stock. On April 5, 2018 pursuant to a conversion notice, $50,000 in principal and $2,256 in interest was converted at $0.05 into 1,088,658 shares of common stock. On April 11, 2018 pursuant to a conversion notice, $20,000 in principal and $929 in interest was converted at $0.04 into 581,358 shares of common stock. On April 12, 2018 pursuant to a conversion notice, $30,000 in principal and $1,289 in interest was converted at $0.04 into 841,095 shares of common stock. On April 18, 2018 pursuant to a conversion notice, $50,000 in principal and $3,750 in interest was converted at $0.03 into 1,560,232 shares of common stock. On April 26, 2018 pursuant to a conversion notice, $35,000 in principal and $3,259 in interest was converted at $0.04 into 1,062,747 shares of common stock On April 30, 2018 pursuant to a conversion notice, $25,000 in principal and $526 in interest was converted at $0.04 into 686,183 shares of common stock April 13, 2018 Securities Purchase Agreement On April 13, 2018, the Company entered into a securities purchase agreement with GS Capital, pursuant to which GS Capital purchased two 8% unsecured convertible promissory notes (the “April 2018 GS Capital Notes”) from the Company each in the principal amount of $150,000. The first note (the “April 2018 GS Capital Note”) was funded with cash and the second note (the “April 2018 Back-End Note”) was initially paid for by an offsetting promissory note issued by GS Capital to the Company (the “April 2018 Note Receivable”). The terms of the April 2018 Back-End Note require cash funding prior to any conversion thereunder. Both the April 2018 GS Capital Note and the April 2018 Back-End Note mature on April 13, 2019, upon which any outstanding principal and interest thereon is due and payable. The amounts cash funded plus accrued interest under both the April 2018 GS Capital Note and the April 2018 Back-End Note are convertibles into shares of the Company’s common stock, at any time after October 13, 2018, at a conversion price for each share of common stock equal to 61% of the lowest closing bid price of the Company’s common stock for the ten prior trading days including the day upon which a notice of conversion is received by the Company from GS Capital, subject to adjustment in certain events. The April 2018 GS Capital Note may be prepaid until 180 days from the issuance date with certain penalties. The April 2018 Back-End Note may not be prepaid. However, in the event that the April 2018 Back-End Note has not been cash paid and the April 2018 GS Capital Note is redeemed within the first six months of issuance, the April 2018 Back-End Note will be deemed cancelled and of no further effect. The April 2018 Back-End Note is not convertible until it is funded in cash on or before December 13, 2018, subject to certain restrictions. The Company has reserved 7,684,000 shares of its common stock for conversions under the April 2018 GS Capital Note. For so long as GS Capital owns any shares of common stock issued upon conversion of the April 2018 GS Capital Notes (the “Conversion Shares”), the Company covenants to (i) secure and maintain the listing of such shares of common stock, (ii) comply with certain of its reporting and filing obligations, and (iii) provide to GS Capital any notices it receives from its listing exchange or quotation system regarding the continued eligibility of its common stock for listing on such exchange. The April 2018 GS Capital Notes contain certain events of default, upon which principal and accrued interest will become immediately due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of 24% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions. Any shares to be issued pursuant to any conversion of the April 2018 GS Capital Notes shall be issued pursuant to an exemption from the registration requirement of the Securities Act provided in Section 4(a)(2) of the Securities Act. GS Capital may not effect any conversions under the April 2018 Back-End Note until it has made full cash payment for the portion of the April 2018 Back-End Note being converted. Any shares to be issued pursuant to any conversion of the April 2018 GS Capital Notes shall be issued pursuant to an exemption from the registration requirement of the Securities Act provided in Section 4(a)(2) of the Securities Act. GS Capital may not effect any conversions under the April 2018 Back-End Note until it has made full cash payment for the portion of the April 2018 Back-End Note being converted. |
Nature of Operations and Summ17
Nature of Operations and Summary of Significant Accounting and Reporting Policies (Policies) | 9 Months Ended |
Mar. 31, 2018 | |
Accounting Policies [Abstract] | |
Nature of Operations | Nature of Operations Propanc Biopharma, Inc. (the “Company,” “we,” “us,” “our” or “Propanc Biopharma”) was originally incorporated in Melbourne, Victoria Australia on October 15, 2007 as Propanc PTY LTD, and continues to be based in Camberwell, Victoria Australia. Since its inception, substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. It is currently in the preclinical phase of development. On November 23, 2010, the Company was incorporated in the state of Delaware as Propanc Health Group Corporation. In January 2011, to reorganize the Company, we acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary of the Company. Effective April 20, 2017, the Company changed its name to “Propanc Biopharma, Inc.” to better reflect the Company’s stage of growth and development. The Company has filed six patent applications relating to its lead product, PRP. The first application was filed in October 2010 in each of the countries listed in the table below. This application has been granted and remains in force in the United States, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore and South Africa. In Brazil, Canada, Hong Kong, Malaysia, Mexico and South Korea, the patent application remains under examination. The patent application in the European Union has recently been accepted. In 2016 and 2017 we filed other patent applications, as indicated below. Three applications were filed under the Patent Cooperation Treaty (the “PCT”). The PCT assists applicants in seeking patent protection by filing one international patent application under the PCT, applicants can then seek protection for an invention in over 150 countries. Once national or regional applications are filed, the application is placed under the control of the national or regional patent offices, as applicable, in what is called the national or regional phase. No. Title Country Case Status Date Filed 1. A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic reduction agent. USA, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore and South Africa Granted Oct-22-2010 Brazil, Canada, Hong Kong, India, Malaysia, Mexico, Republic of Korea Under Examination Europe Accepted 2. Proenzyme composition PCT Application filed and pending Nov-11-2016 3. Cancer Treatment PCT Application filed and pending Jan-27-2017 4. Composition of proenzymes for cancer treatment PCT Application filed and pending Apr-12-2017 The Company hopes to capture and protect additional patentable subject matter based on the Company’s field of technology relating to pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product candidate, PRP, through various stages of development. On April 20, 2017, the Company filed a certificate of amendment to its certificate of incorporation whereby the Company (i) decreased the number of authorized shares of common stock, par value $0.001 per share (the “Common Stock”) to 100,000,000 (ii) decreased the number of authorized shares of preferred stock to 1,500,005 and (iii) effected a one-for-two hundred and fifty (1:250) reverse stock split of its issued and outstanding shares of Common Stock. Proportional adjustments for the reverse stock split were made to the Company’s outstanding stock options, warrants and equity incentive plans, including all share and per-share data, for all amounts and periods presented in the unaudited consolidated financial statements. On January 23, 2018, Company filed a certificate of amendment to its certificate of incorporation to increase in the number of authorized shares of the Company’s common stock from 100,000,000 to 400,000,000. |
Basis of Presentation | Basis of Presentation The interim unaudited consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations for the three and nine months ended March 31, 2018 and 2017 and cash flows for the nine months ended March 31, 2018 and 2017 and our financial position at March 31, 2018 have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year. Reference is frequently made herein to the Financial Accounting Standards Board (the “FASB”) Accounting Standards Codification (“ASC”). This is the source of authoritative US GAAP recognized by the FASB to be applied to non-governmental entities. Each ASC reference in this filing is presented with a three-digit number, which represents its Topic. As necessary for explanation and as applicable, an ASC topic may be followed with a two-digit subtopic, a two-digit section or a two-or-three-digit paragraph. Certain information and disclosures normally included in the notes to the annual audited consolidated financial statements have been condensed or omitted from these interim unaudited consolidated financial statements. Accordingly, these interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2017. The June 30, 2017 balance sheet is derived from those statements. |
Principles of Consolidation | Principles of Consolidation The unaudited consolidated financial statements include the accounts of Propanc Biopharma, Inc. and its wholly-owned subsidiary, Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying unaudited consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates. |
Foreign Currency Translation and Other Comprehensive Income (Loss) | Foreign Currency Translation and Other Comprehensive Income (Loss) The Company’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into United States dollars ($ and/or USD) as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the statement of operations and comprehensive income (loss) as other income (expense). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Other Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses). As of March 31, 2018, and June 30, 2017, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing the unaudited consolidated financial statements were as follows: March 31, 2018 June 30, 2017 Exchange rate on balance sheet dates USD : AUD exchange rate 0.7816 0.7676 Average exchange rate for the period USD : AUD exchange rate 0.7690 0.7544 Changes in Accumulated Other Comprehensive Income (Loss) by Component during the nine months ended March 31, 2018 was as follows: Foreign Currency Items: Beginning balance, June 30, 2017 $ (141,749 ) Foreign currency translation gain 28,370 Ending balance, March 31, 2018 $ (113,379 ) |
Fair Value of Financial Instruments and Fair Value Measurements | Fair Value of Financial Instruments and Fair Value Measurements The Company measures its financial assets and liabilities in accordance with US GAAP. For certain of the Company’s financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued expenses and other liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for loans payable, also approximate fair value because current interest rates available to us for debt with similar terms and maturities are substantially the same. The Company has adopted ASC 820, “ Fair Value Measurement, Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. The estimated fair value of certain financial instruments, including accounts receivable and accounts payable are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The cost basis of notes and convertible debentures approximates fair value due to the market interest rates carried for these instruments. Also see Note 10 - Derivative Financial Instruments. |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were no cash equivalents as of March 31, 2018 or June 30, 2017. |
Patents | Patents Patents are stated at cost and reclassified to intangible assets and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency. However, the Company will expense any product costs for so long as we remain in the startup stage. Accordingly, as the Company’s products were and are not currently approved for market, all patent costs incurred from 2013 through March 31, 2018 were expensed immediately. This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency. |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets In accordance with ASC 360-10, “ Long-lived assets,” |
Australian Goods and Services Tax (GST) | Australian Goods and Services Tax (GST) Revenues, expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office. Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows. As of March 31, 2018, and June 30, 2017, the Company was owed $2,357 and $8,111, respectively, from the Australian Taxation Office. These amounts were fully collected subsequent to the balance sheet reporting dates. |
Derivative Instruments | Derivative Instruments ASC Topic 815, Derivatives and Hedging |
Convertible Notes with Variable Conversion Options | Convertible Notes With Variable Conversion Options The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, “ Distinguishing Liabilities from Equity |
Income Taxes | Income Taxes The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows ASC 740 “ Accounting for Income Taxes The Company adopted provisions of ASC 740, Sections 25 through 60, “ Accounting for Uncertainty in Income Taxes |
Research and Development Costs and Tax Credits | Research and Development Costs and Tax Credits In accordance with ASC 730-10, “Research and Development-Overall,” The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company’s net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as an income tax benefit, in operations, upon receipt. During the nine months ended March 31, 2018 and 2017, the Company applied for, and received from the Australian Taxation Office, a research and development tax credit in the amount of $180,763 and $306,159 respectively, which is reflected as a tax benefit in the accompanying consolidated statements of operations and comprehensive income (loss). |
Stock Based Compensation | Stock Based Compensation The Company records stock-based compensation in accordance with ASC 718, “ Stock Compensation Share Based Payment The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 “ Equity-Based Payments to Non-Employees |
Basic and Diluted Net Loss Per Common Share | Basic and Diluted Net Loss Per Common Share Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. As of March 31, 2018, there were 149,517 warrants outstanding, 572,000 stock options and 18 convertible notes payable, which notes are convertible into 57,448,803 common shares. Such securities are considered dilutive securities which were excluded from the computation since the effect is anti-dilutive. |
Recently Adopted Accounting Pronouncements | Recently Adopted Accounting Pronouncements Certain FASB Accounting Standard Updates (“ASU”) that are not effective until after March 31, 2018 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations. The Company is evaluating or has implemented the following at March 31, 2018: In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments In February 2016, the FASB issued ASU 2016-02, “Leases,” |
Nature of Operations and Summ18
Nature of Operations and Summary of Significant Accounting and Reporting Policies (Tables) | 9 Months Ended |
Mar. 31, 2018 | |
Accounting Policies [Abstract] | |
Schedule of Translation Exchange Rates | As of March 31, 2018, and June 30, 2017, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing the unaudited consolidated financial statements were as follows: March 31, 2018 June 30, 2017 Exchange rate on balance sheet dates USD : AUD exchange rate 0.7816 0.7676 Average exchange rate for the period USD : AUD exchange rate 0.7690 0.7544 |
Schedule of Changes in Accumulated Other Comprehensive Income (Loss) | Changes in Accumulated Other Comprehensive Income (Loss) by Component during the nine months ended March 31, 2018 was as follows: Foreign Currency Items: Beginning balance, June 30, 2017 $ (141,749 ) Foreign currency translation gain 28,370 Ending balance, March 31, 2018 $ (113,379 ) |
Convertible Notes (Tables)
Convertible Notes (Tables) | 9 Months Ended |
Mar. 31, 2018 | |
Debt Disclosure [Abstract] | |
Schedule of Convertible Notes | Convertible notes outstanding at March 31, 2018 were as follows: Convertible notes and debenture $ 3,128,435 Unamortized discounts (446,682 ) Accrued interest 124,394 Premium 1,708,774 Convertible notes, net $ 4,514,921 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 9 Months Ended |
Mar. 31, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Future Minimum Rental Payments for Operating Leases | Future minimum operating lease commitments consisted of the following at March 31, 2018: Fiscal Year Ended June 30, Amount (USD) Remainder 2018 $ 7,613 2019 $ 30,452 2020 $ 30,452 2021 $ 25,377 |
Derivative Financial Instrume21
Derivative Financial Instruments and Fair Value Measurements (Tables) | 9 Months Ended |
Mar. 31, 2018 | |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of March 31 2018: Quoted Prices in Active Significant Markets for Other Significant Balance at March 31, 2018 Identical Assets Observable Inputs Unobservable Inputs (Level 1) (Level 2) (Level 3) Embedded conversion option liabilities $ 555,166 $ — $ — $ 555,166 Total $ 555,166 $ — $ — $ 555,166 |
Schedule of Derivative Liabilities at Fair Value | The following is a roll forward for the nine months ended March 31, 2018 of the fair value liability of price adjustable derivative instruments: Fair Value of Liability for Derivative Instruments Balance at June 30, 2017 $ 881,172 Effects of foreign currency exchange rate changes 70 Reductions due to conversions (658,772 ) Reductions due to repayment of debt (199,339 ) Initial fair value of embedded conversion option derivative liability recorded as debt discount 510,000 Initial fair value of embedded conversion option derivative liability recorded as change in fair value of embedded conversion option 313,694 Change in fair value included in statements of operations (291,659 ) Balance at March 31, 2018 $ 555,166 |
Warrants [Member] | |
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques | Warrants March 31, 2018 Volatility 246.60 % Expected remaining term (in years) .5 Risk-free interest rate 1.93 % Expected dividend yield None |
Convertible Debt [Member] | |
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques | Convertible Debt Initial Valuations (on new derivative instruments March 31, 2018) March 31, 2018 Volatility 195.25% - 198.43 % 167.81% – 192.32 % Expected Remaining Term (in years) 1 .93 - 1.36 Risk Free Interest Rate 1.79% - 2.06 % 1.87% - 2.09 % Expected dividend yield None None |
Nature of Operations and Summ22
Nature of Operations and Summary of Significant Accounting and Reporting Policies (Details Narrative) - USD ($) | Apr. 20, 2017 | Mar. 31, 2018 | Mar. 31, 2017 | Mar. 31, 2018 | Mar. 31, 2017 | Jan. 23, 2018 | Jun. 30, 2017 |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | |||
Common stock, shares authorized | 100,000,000 | 400,000,000 | 400,000,000 | 400,000,000 | 400,000,000 | ||
Preferred stock, shares authorized | 1,500,005 | 1,500,005 | 1,500,005 | ||||
Reverse stock split | one-for-two hundred and fifty (1:250) | ||||||
Cash equivalents | |||||||
Value added tax receivable | 2,357 | 2,357 | $ 8,111 | ||||
Research and development costs | 75,138 | $ 386,490 | 1,673,606 | $ 714,889 | |||
Research and development tax credit | $ 485 | $ 306,159 | $ 180,763 | $ 306,159 | |||
Stock Options [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Antidilutive securities excluded from computation of earnings per share, amount | 572,000 | ||||||
Convertible Notes Payable [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Antidilutive securities excluded from computation of earnings per share, amount | 18 | ||||||
Warrants [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Antidilutive securities excluded from computation of earnings per share, amount | 149,517 | ||||||
Common Stock [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Antidilutive securities excluded from computation of earnings per share, amount | 57,448,803 |
Nature of Operations and Summ23
Nature of Operations and Summary of Significant Accounting and Reporting Policies - Schedule of Translation Exchange Rates (Details) | Mar. 31, 2018 | Jun. 30, 2017 |
USD : AUD exchange rate | 0.7816 | 0.7676 |
Weighted Average [Member] | ||
USD : AUD exchange rate | 0.7690 | 0.7544 |
Nature of Operations and Summ24
Nature of Operations and Summary of Significant Accounting and Reporting Policies - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2018 | Mar. 31, 2017 | Mar. 31, 2018 | Mar. 31, 2017 | |
Accounting Policies [Abstract] | ||||
Beginning balance | $ (141,749) | |||
Foreign currency translation gain | $ 198,634 | $ (473,998) | 28,370 | $ (217,100) |
Ending balance | $ (113,379) | $ (113,379) |
Going Concern (Details Narrativ
Going Concern (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2018 | Mar. 31, 2017 | Mar. 31, 2018 | Mar. 31, 2017 | Jun. 30, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||
Revenues | |||||
Net loss | 1,491,006 | $ 1,371,126 | 5,616,728 | 6,234,008 | |
Net cash used in operating activities | 1,730,085 | $ 1,449,080 | |||
Working capital deficit | 6,784,373 | 6,784,373 | |||
Stockholders' deficit | 6,772,914 | 6,772,914 | $ 5,441,751 | ||
Accumulated deficit | $ 43,860,251 | $ 43,860,251 | $ 38,243,523 |
Due to Directors - Related Pa26
Due to Directors - Related Parties (Details Narrative) - USD ($) | 9 Months Ended | |
Mar. 31, 2018 | Jun. 30, 2017 | |
Due To Directors - Related Parties | ||
Due to directors - related parties | $ 34,192 | $ 35,204 |
Repayment of related party debt | $ 1,077 |
Loans and Notes Payable (Detail
Loans and Notes Payable (Details Narrative) - USD ($) | Mar. 31, 2018 | Jun. 30, 2017 |
Unrelated Parties [Member] | ||
Other loans payable | $ 0 | $ 2,303 |
Directors and Officer [Member] | ||
Loans payable | $ 56,906 | $ 56,802 |
Convertible Notes (Details Narr
Convertible Notes (Details Narrative) - USD ($) | Jul. 24, 2018 | Mar. 23, 2018 | Mar. 12, 2018 | Mar. 05, 2018 | Jan. 29, 2018 | Jan. 22, 2018 | Jan. 02, 2018 | Dec. 29, 2017 | Dec. 06, 2017 | Nov. 03, 2017 | Sep. 21, 2017 | Sep. 14, 2017 | Aug. 10, 2017 | Aug. 09, 2017 | Jul. 24, 2017 | Jul. 05, 2017 | Jun. 03, 2017 | May 26, 2017 | May 04, 2017 | Apr. 11, 2017 | Mar. 02, 2017 | Feb. 16, 2017 | Jan. 27, 2017 | Dec. 21, 2016 | Dec. 12, 2016 | Nov. 18, 2016 | Nov. 18, 2016 | Sep. 13, 2016 | Mar. 31, 2018 | Mar. 31, 2017 | Mar. 31, 2018 | Mar. 31, 2017 | Feb. 27, 2018 | Jan. 25, 2018 | Dec. 31, 2017 | Jun. 30, 2017 | Dec. 02, 2016 | Oct. 28, 2015 |
Convertible debenture | $ 516,000 | $ 516,000 | ||||||||||||||||||||||||||||||||||||
Derivative liability of convertible debenture | 555,166 | 555,166 | $ 881,172 | |||||||||||||||||||||||||||||||||||
Gain (loss) on extinguishment of debt, net | 240,301 | 156,574 | ||||||||||||||||||||||||||||||||||||
Long-term debt | 3,128,435 | 3,128,435 | ||||||||||||||||||||||||||||||||||||
Debt premium amount | 1,708,774 | 1,708,774 | ||||||||||||||||||||||||||||||||||||
Repayment of convertible debt | 490,181 | |||||||||||||||||||||||||||||||||||||
Net cash proceeds of convertible debt | 2,385,781 | 923,750 | ||||||||||||||||||||||||||||||||||||
Embedded derivative, fair value of embedded derivative liability | 555,166 | 555,166 | ||||||||||||||||||||||||||||||||||||
Debt instrument, unamortized discount | 446,682 | 446,682 | ||||||||||||||||||||||||||||||||||||
Amortization of debt discount | 628,066 | $ 1,835,899 | ||||||||||||||||||||||||||||||||||||
Eagle Equities, LLC [Member] | October Note [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 200,000 | 200,000 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 6,619 | 6,619 | ||||||||||||||||||||||||||||||||||||
Eagle Equities, LLC [Member] | December 21 Note [Member] | ||||||||||||||||||||||||||||||||||||||
Accrued interest | 7,773 | 7,773 | ||||||||||||||||||||||||||||||||||||
Eagle Equities, LLC [Member] | January Eagle Back End Note [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 230,000 | 230,000 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 15,487 | 15,487 | ||||||||||||||||||||||||||||||||||||
Eagle Equities, LLC [Member] | March Eagle Back End Note [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 220,500 | 220,500 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 13,049 | 13,049 | ||||||||||||||||||||||||||||||||||||
Eagle Equities, LLC [Member] | August Eagle Back End Note [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 200,000 | 200,000 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 8,732 | 8,732 | ||||||||||||||||||||||||||||||||||||
Eagle Equities, LLC [Member] | October Eagle Back-End Note [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 200,000 | 200,000 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 5,085 | 5,085 | ||||||||||||||||||||||||||||||||||||
Initial Securities Purchase Agreement [Member] | Delafield Investments Limited [Member] | ||||||||||||||||||||||||||||||||||||||
Purchaser for investment amount | $ 4,000,000 | |||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 5.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 4,350,000 | |||||||||||||||||||||||||||||||||||||
Warrants to purchase of common stock, shares | 104,762 | |||||||||||||||||||||||||||||||||||||
Convertible debenture | $ 340,181 | 720,271 | ||||||||||||||||||||||||||||||||||||
Derivative liability of convertible debenture | 252,303 | |||||||||||||||||||||||||||||||||||||
Debt conversion of converted amount | 380,090 | |||||||||||||||||||||||||||||||||||||
Accrued interest | 8,250 | 8,250 | ||||||||||||||||||||||||||||||||||||
Gain (loss) on extinguishment of debt, net | 199,339 | |||||||||||||||||||||||||||||||||||||
Additional Issuance Agreement [Member] | ||||||||||||||||||||||||||||||||||||||
Long-term debt | $ 150,000 | |||||||||||||||||||||||||||||||||||||
Debt original issue discount, rate | 5.00% | |||||||||||||||||||||||||||||||||||||
Additional Issuance Debenture [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 165,000 | |||||||||||||||||||||||||||||||||||||
Convertible debenture | 165,000 | 165,000 | 165,000 | |||||||||||||||||||||||||||||||||||
Derivative liability of convertible debenture | 54,727 | |||||||||||||||||||||||||||||||||||||
Accrued interest | 8,250 | 8,250 | 8,250 | |||||||||||||||||||||||||||||||||||
December Letter Agreement [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 150,000 | |||||||||||||||||||||||||||||||||||||
Warrants to purchase of common stock, shares | 960,000 | |||||||||||||||||||||||||||||||||||||
Convertible debenture | 150,000 | 150,000 | ||||||||||||||||||||||||||||||||||||
Accrued interest | $ 16,899 | 6,937 | ||||||||||||||||||||||||||||||||||||
December 12, 2016 Securities Purchase Agreement [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debenture | 8,296 | 8,296 | ||||||||||||||||||||||||||||||||||||
December 12, 2016 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 100,000 | |||||||||||||||||||||||||||||||||||||
Convertible debenture | 100,000 | 100,000 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 7,781 | $ 7,781 | ||||||||||||||||||||||||||||||||||||
Debt maturity date | Dec. 12, 2017 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 60.00% | |||||||||||||||||||||||||||||||||||||
Payment of notes receivable | $ 100,000 | |||||||||||||||||||||||||||||||||||||
Legal fees | 5,000 | |||||||||||||||||||||||||||||||||||||
Proceed from note receivable net | 95,000 | |||||||||||||||||||||||||||||||||||||
Debt premium amount | $ 66,667 | |||||||||||||||||||||||||||||||||||||
Debt instrument, default, interest rate | 24.00% | |||||||||||||||||||||||||||||||||||||
December 12, 2016 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | December 21 Eagle Back End Note [Member] | ||||||||||||||||||||||||||||||||||||||
Accrued interest | 5,656 | $ 5,656 | ||||||||||||||||||||||||||||||||||||
December 21, 2016 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 157,500 | |||||||||||||||||||||||||||||||||||||
Debt maturity date | Dec. 21, 2017 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 60.00% | |||||||||||||||||||||||||||||||||||||
Payment of notes receivable | $ 157,500 | |||||||||||||||||||||||||||||||||||||
Legal fees | 7,500 | |||||||||||||||||||||||||||||||||||||
Proceed from note receivable net | 150,000 | |||||||||||||||||||||||||||||||||||||
Debt premium amount | 105,000 | |||||||||||||||||||||||||||||||||||||
January 27, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 190,000 | $ 230,000 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 14,988 | 14,988 | ||||||||||||||||||||||||||||||||||||
Debt maturity date | Sep. 27, 2017 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 60.00% | |||||||||||||||||||||||||||||||||||||
Payment of notes receivable | $ 40,000 | |||||||||||||||||||||||||||||||||||||
Legal fees | $ 11,250 | |||||||||||||||||||||||||||||||||||||
Debt premium amount | 153,333 | $ 153,333 | ||||||||||||||||||||||||||||||||||||
Debt instrument, default, interest rate | 24.00% | |||||||||||||||||||||||||||||||||||||
March 1, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 220,500 | |||||||||||||||||||||||||||||||||||||
Convertible debenture | 168,500 | $ 168,500 | ||||||||||||||||||||||||||||||||||||
Debt conversion of converted amount | 52,000 | |||||||||||||||||||||||||||||||||||||
Accrued interest | 14,616 | 14,616 | ||||||||||||||||||||||||||||||||||||
Debt maturity date | Mar. 1, 2018 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 60.00% | |||||||||||||||||||||||||||||||||||||
Payment of notes receivable | $ 220,500 | |||||||||||||||||||||||||||||||||||||
Legal fees | 10,500 | |||||||||||||||||||||||||||||||||||||
Proceed from note receivable net | $ 210,000 | |||||||||||||||||||||||||||||||||||||
Debt premium amount | 147,000 | $ 147,000 | ||||||||||||||||||||||||||||||||||||
Debt instrument, default, interest rate | 24.00% | |||||||||||||||||||||||||||||||||||||
August 9, 2017 Securities Purchase Agreement [Member] | August Note [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 150,000 | $ 150,000 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 8,147 | 8,147 | ||||||||||||||||||||||||||||||||||||
August 9, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 200,000 | |||||||||||||||||||||||||||||||||||||
Debt conversion of converted amount | 50,000 | |||||||||||||||||||||||||||||||||||||
Debt maturity date | Aug. 8, 2018 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 60.00% | |||||||||||||||||||||||||||||||||||||
Payment of notes receivable | $ 200,000 | |||||||||||||||||||||||||||||||||||||
Legal fees | 10,000 | |||||||||||||||||||||||||||||||||||||
Proceed from note receivable net | $ 190,000 | |||||||||||||||||||||||||||||||||||||
Debt premium amount | 133,333 | $ 133,333 | ||||||||||||||||||||||||||||||||||||
Debt instrument, default, interest rate | 24.00% | |||||||||||||||||||||||||||||||||||||
October 25, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 200,000 | |||||||||||||||||||||||||||||||||||||
Debt maturity date | Jun. 25, 2018 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 60.00% | |||||||||||||||||||||||||||||||||||||
Payment of notes receivable | $ 200,000 | |||||||||||||||||||||||||||||||||||||
Legal fees | 10,000 | |||||||||||||||||||||||||||||||||||||
Debt premium amount | 133,333 | |||||||||||||||||||||||||||||||||||||
Debt instrument, default, interest rate | 24.00% | |||||||||||||||||||||||||||||||||||||
Net cash proceeds of convertible debt | $ 190,000 | |||||||||||||||||||||||||||||||||||||
Conversion price, per share | $ 0.001 | |||||||||||||||||||||||||||||||||||||
December 29, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 532,435 | |||||||||||||||||||||||||||||||||||||
December 29, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | December 2017 Eagle Note [Member] | ||||||||||||||||||||||||||||||||||||||
Debt conversion of convertible debt amount | 25,354 | |||||||||||||||||||||||||||||||||||||
Amortization of debt discount | $ 507,081 | |||||||||||||||||||||||||||||||||||||
December 29, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | December 2017 Eagle Note [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 532,435 | $ 532,435 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 10,386 | 10,386 | ||||||||||||||||||||||||||||||||||||
Debt maturity date | Dec. 29, 2018 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 60.00% | |||||||||||||||||||||||||||||||||||||
Debt premium amount | 354,956 | 354,956 | ||||||||||||||||||||||||||||||||||||
December 12, 2016, December 21, 2016, January 27, 2017, and March 1, 2017 and August 9, 2017, October 25, 2017 and the December 29, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 2,001,435 | 2,001,435 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 89,893 | 89,893 | ||||||||||||||||||||||||||||||||||||
May 26, 2017 Securities Purchase Agreement [Member] | GS Capital Partners, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 160,000 | |||||||||||||||||||||||||||||||||||||
Accrued interest | 7,499 | 7,499 | ||||||||||||||||||||||||||||||||||||
Debt maturity date | May 26, 2018 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 62.00% | |||||||||||||||||||||||||||||||||||||
Debt premium amount | $ 98,065 | |||||||||||||||||||||||||||||||||||||
July 24, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 160,000 | 160,000 | 160,000 | |||||||||||||||||||||||||||||||||||
Debt conversion of converted amount | 135,000 | |||||||||||||||||||||||||||||||||||||
Accrued interest | 1,405 | 1,405 | ||||||||||||||||||||||||||||||||||||
Debt maturity date | Mar. 24, 2018 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 62.00% | |||||||||||||||||||||||||||||||||||||
Legal fees | 8,000 | |||||||||||||||||||||||||||||||||||||
Proceed from note receivable net | $ 152,000 | |||||||||||||||||||||||||||||||||||||
Debt premium amount | $ 98,065 | |||||||||||||||||||||||||||||||||||||
Debt instrument, default, interest rate | 24.00% | |||||||||||||||||||||||||||||||||||||
July 24, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | July 2017 GS Note and July 2017 GS Back-End Note [Member] | ||||||||||||||||||||||||||||||||||||||
Debt maturity date | Jul. 24, 2018 | |||||||||||||||||||||||||||||||||||||
July 24, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | July 2017 GS Note [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 25,000 | $ 25,000 | $ 160,000 | |||||||||||||||||||||||||||||||||||
July 24, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | July GS Back-End Note [Member] | ||||||||||||||||||||||||||||||||||||||
Accrued interest | 2,279 | 2,279 | ||||||||||||||||||||||||||||||||||||
September 21, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 160,000 | 160,000 | 160,000 | |||||||||||||||||||||||||||||||||||
Accrued interest | 7,049 | 7,049 | ||||||||||||||||||||||||||||||||||||
Debt maturity date | Mar. 24, 2018 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 62.00% | |||||||||||||||||||||||||||||||||||||
Legal fees | 8,000 | |||||||||||||||||||||||||||||||||||||
Proceed from note receivable net | $ 152,000 | |||||||||||||||||||||||||||||||||||||
Debt premium amount | $ 98,065 | |||||||||||||||||||||||||||||||||||||
Debt instrument, default, interest rate | 24.00% | |||||||||||||||||||||||||||||||||||||
September 21, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | September Back-End Note [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 160,000 | $ 160,000 | $ 160,000 | |||||||||||||||||||||||||||||||||||
Accrued interest | 1,122 | 1,122 | ||||||||||||||||||||||||||||||||||||
March 23, 2018 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 106,000 | 106,000 | 106,000 | |||||||||||||||||||||||||||||||||||
Accrued interest | 185 | $ 185 | ||||||||||||||||||||||||||||||||||||
Debt maturity date | Nov. 23, 2018 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 62.00% | |||||||||||||||||||||||||||||||||||||
Debt premium amount | $ 64,968 | |||||||||||||||||||||||||||||||||||||
Debt instrument, default, interest rate | 24.00% | |||||||||||||||||||||||||||||||||||||
May 26, 2017, July 24, 2017, September 21, 2017 and the March 23, 2018 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 611,000 | $ 611,000 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 12,041 | 12,041 | ||||||||||||||||||||||||||||||||||||
Regal Consulting Agreement [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 250,000 | $ 250,000 | 19,639 | 19,639 | ||||||||||||||||||||||||||||||||||
Debt instrument, term | 2 years | |||||||||||||||||||||||||||||||||||||
Regal Consulting Agreement [Member] | First Convertible Note [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 250,000 | $ 250,000 | 27,500 | |||||||||||||||||||||||||||||||||||
Accrued interest | 1,664 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 65.00% | |||||||||||||||||||||||||||||||||||||
Embedded derivative, fair value of embedded derivative liability | $ 255,757 | $ 255,757 | ||||||||||||||||||||||||||||||||||||
Conversion price, per share | $ 2.50 | $ 2.50 | ||||||||||||||||||||||||||||||||||||
Regal Consulting Agreement [Member] | Second Convertible Note [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 250,000 | |||||||||||||||||||||||||||||||||||||
Accrued interest | 31,021 | 31,021 | ||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 65.00% | |||||||||||||||||||||||||||||||||||||
Embedded derivative, fair value of embedded derivative liability | $ 409,416 | |||||||||||||||||||||||||||||||||||||
Conversion price, per share | $ 2.50 | |||||||||||||||||||||||||||||||||||||
August 10, 2017 Securities Purchase Agreement [Member] | ||||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 10.00% | |||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 310,000 | 310,000 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 19,874 | 19,874 | ||||||||||||||||||||||||||||||||||||
Debt maturity date | Aug. 10, 2019 | |||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 65.00% | |||||||||||||||||||||||||||||||||||||
Debt instrument, default, interest rate | 18.00% | |||||||||||||||||||||||||||||||||||||
Embedded derivative, fair value of embedded derivative liability | $ 578,212 | |||||||||||||||||||||||||||||||||||||
Conversion price, per share | $ 1.50 | |||||||||||||||||||||||||||||||||||||
Convertible notes payable | $ 310,000 | |||||||||||||||||||||||||||||||||||||
Accrued expenses | $ 155,000 | $ 155,000 | ||||||||||||||||||||||||||||||||||||
Debt instrument, unamortized discount | 310,000 | 310,000 | ||||||||||||||||||||||||||||||||||||
Power Up Lending Group Finance Agreements [Member] | ||||||||||||||||||||||||||||||||||||||
Purchaser for investment amount | 53,000 | 53,000 | ||||||||||||||||||||||||||||||||||||
Debt instrument, interest rate, stated percentage | 8.00% | 8.00% | ||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | $ 53,000 | $ 153,000 | ||||||||||||||||||||||||||||||||||||
Derivative liability of convertible debenture | $ 65,231 | $ 180,251 | ||||||||||||||||||||||||||||||||||||
Accrued interest | 302 | 302 | ||||||||||||||||||||||||||||||||||||
Debt maturity date | Mar. 5, 2019 | Jan. 22, 2019 | ||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 65.00% | 65.00% | ||||||||||||||||||||||||||||||||||||
Legal fees | $ 2,500 | $ 2,500 | ||||||||||||||||||||||||||||||||||||
Proceed from note receivable net | 53,000 | 153,000 | ||||||||||||||||||||||||||||||||||||
Conversion price, per share | $ 0.065 | $ 0.065 | ||||||||||||||||||||||||||||||||||||
Debt instrument, unamortized discount | 510,000 | 510,000 | ||||||||||||||||||||||||||||||||||||
Diligence fees | 500 | 500 | ||||||||||||||||||||||||||||||||||||
Net cash proceeds from convertible promissory note | $ 50,000 | $ 150,000 | ||||||||||||||||||||||||||||||||||||
Debt instrument market price per share | $ 0.10 | $ 0.10 | ||||||||||||||||||||||||||||||||||||
Percentage of outstanding shares of common stock | 4.99% | 4.99% | ||||||||||||||||||||||||||||||||||||
Power Up Lending Group Finance Agreements [Member] | July 21, 2018 [Member] | ||||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 150.00% | |||||||||||||||||||||||||||||||||||||
Power Up Lending Group Finance Agreements [Member] | September 1, 2018 [Member] | ||||||||||||||||||||||||||||||||||||||
Common stock trading volume, percent | 150.00% | |||||||||||||||||||||||||||||||||||||
Power Up Lending Group Finance Agreements [Member] | January 2018 [Member] | ||||||||||||||||||||||||||||||||||||||
Convertible debt principal amount | 153,000 | 153,000 | ||||||||||||||||||||||||||||||||||||
Accrued interest | $ 2,280 | $ 2,280 |
Convertible Notes - Schedule of
Convertible Notes - Schedule of Convertible Notes (Details) | Mar. 31, 2018USD ($) |
Debt Disclosure [Abstract] | |
Convertible notes and debenture | $ 3,128,435 |
Unamortized discounts | (446,682) |
Accrued interest | 124,394 |
Premium | 1,708,774 |
Convertible notes, net | $ 4,514,921 |
Stockholders' Deficit (Details
Stockholders' Deficit (Details Narrative) - USD ($) | Mar. 26, 2018 | Mar. 21, 2018 | Mar. 16, 2018 | Mar. 14, 2018 | Mar. 11, 2018 | Mar. 08, 2018 | Mar. 05, 2018 | Mar. 04, 2018 | Feb. 28, 2018 | Feb. 23, 2018 | Feb. 23, 2018 | Feb. 21, 2018 | Feb. 15, 2018 | Feb. 13, 2018 | Feb. 04, 2018 | Feb. 02, 2018 | Jan. 31, 2018 | Jan. 30, 2018 | Jan. 26, 2018 | Jan. 12, 2018 | Jan. 09, 2018 | Jan. 04, 2018 | Jan. 03, 2018 | Jan. 02, 2018 | Dec. 29, 2017 | Dec. 22, 2017 | Dec. 21, 2017 | Dec. 19, 2017 | Dec. 18, 2017 | Dec. 15, 2017 | Dec. 11, 2017 | Dec. 08, 2017 | Dec. 06, 2017 | Dec. 01, 2017 | Nov. 27, 2017 | Nov. 26, 2017 | Nov. 17, 2017 | Nov. 15, 2017 | Nov. 13, 2017 | Nov. 08, 2017 | Nov. 06, 2017 | Nov. 02, 2017 | Oct. 30, 2017 | Oct. 27, 2017 | Oct. 24, 2017 | Oct. 23, 2017 | Oct. 19, 2017 | Oct. 18, 2017 | Oct. 16, 2017 | Oct. 11, 2017 | Oct. 10, 2017 | Oct. 09, 2017 | Oct. 05, 2017 | Oct. 04, 2017 | Oct. 02, 2017 | Sep. 26, 2017 | Sep. 25, 2017 | Sep. 18, 2017 | Sep. 14, 2017 | Sep. 08, 2017 | Sep. 06, 2017 | Sep. 03, 2017 | Aug. 29, 2017 | Aug. 25, 2017 | Aug. 22, 2017 | Aug. 17, 2017 | Aug. 16, 2017 | Aug. 02, 2017 | Jul. 31, 2017 | Jul. 28, 2017 | Jul. 20, 2017 | Jul. 17, 2017 | Jul. 13, 2017 | Jul. 05, 2017 | May 10, 2017 | Apr. 14, 2017 | Apr. 14, 2016 | Mar. 31, 2018 | Mar. 31, 2017 | Mar. 31, 2018 | Mar. 31, 2017 | Jun. 30, 2017 | Apr. 20, 2017 | Jun. 16, 2015 | Dec. 09, 2014 |
Preferred stock, shares authorized | 1,500,005 | 1,500,005 | 1,500,005 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, par value | $ 0.01 | $ 0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock voting rights description | Each holder of outstanding shares of Series A Preferred Stock shall be entitled to voting power equivalent to two shares of Common stock for each share of Series A Preferred Stock held and entitled to vote on all matters, except election or removal of directors of the Company, submitted to a vote of the stockholders of the Company. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consulting expenses | $ 70,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of common shares issued for services | 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss on settlement of debt | $ (71,151) | $ (343) | $ (34,337) | $ (131,900) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share issued price per share | $ 0.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consulting fee | 17,835 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preparation for certain marketing materials | $ 9,772 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of restricted shares issued | 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bonus percentage | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of common shares issued | 130,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of shares vested | 95,333 | 95,333 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock option expire date | Apr. 14, 2021 | Apr. 14, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share based compensation arrangement by share based payment award options grant date fair value | $ 3,924,880 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock based expense | 491,058 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unrecognized stock option expense | $ 163,089 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of warrants outstanding | 12,000 | 12,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Second Anniversary [Member] | April 14, 2018 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of shares vested | 95,333 | 95,333 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock option expire date | Apr. 14, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chief Executive Officer [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of shares granted | 286,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Granted exercise price | $ 7.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share based compensation arrangement by share based payment award options grant date fair value | $ 1,962,440 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Director [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of shares granted | 286,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Granted exercise price | $ 7.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lender [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of common shares issued | 98,727,377 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of common shares issued for services, value | $ 30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of warrants outstanding | 149,517 | 149,517 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrant outstanding exercisable expiration | expiration dates commencing December 2018 and continuing through November 2020. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued One [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 26,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,121 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.54 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 49,946 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Two [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 42,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 67,694 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Three [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 16,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 732 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.40 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 41,623 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Four [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 28,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,300 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 101,738 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Five [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 22,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,593 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 93,365 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Six [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 70,897 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Seven [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,233 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 124,921 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Eight [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,311 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.23 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 112,441 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Nine [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 66,171 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Ten [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 84,812 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Eleven [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,361 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.23 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 112,654 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Twelve [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 81,926 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Thirteen [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,661 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 106,390 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Fourteen [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 12,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 714 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 71,042 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Fifteen [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 83,247 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Sixteen [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 450 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 103,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Seventeen [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,665 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 138,878 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Eighteen [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 107,527 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Nineteen [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 649 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 149,630 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Twenty [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 168,303 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Twenty One [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,716 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 145,257 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Twenty Two [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 850 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 187,319 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Twenty Three [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 40,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 224,404 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Twenty Four [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,716 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 145,257 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Twenty Five [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,067 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 215,651 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Twenty Six [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 45,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 241,835 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Twenty Seven [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,812 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 139,762 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Twenty Eight [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,834 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 134,363 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Twenty Nine [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 939 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 196,507 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Thirty [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 193,549 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Thirty One [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,884 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 198,045 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Thirty Two [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 21,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 817 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 202,006 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Thirty Three [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 159,958 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Thirty Four [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 8,750 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 352 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 144,475 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Thirty Five [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,902 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 300,851 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Thirty Six [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 8,250 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 155,426 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Thirty Seven [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 12,750 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 533 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 245,158 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Thirty Eight [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 17,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 250,897 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Thirty Nine [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 2,356 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 382,153 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Forty [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 11,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 623 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 215,247 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Forty One [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 2,443 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 383,641 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Forty Two [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 215,054 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Forty Three [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 2,568 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 385,777 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Forty Four [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,196 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 392,510 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Forty Five [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 802 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 372,799 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Forty Six [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 21,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,297 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 412,914 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Forty Seven [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 9,900 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 792 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 198,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Forty Eight [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 42,666 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 611,699 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Forty Nine [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 9,900 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 799 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 198,122 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Fifty [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 27,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,142 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 504,339 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Fifty One [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 42,666 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 611,699 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Fifty Two [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 56,758 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.08 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 732,362 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Fifty Three [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 2,467 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 478,859 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Fifty Four [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 23,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,013 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 368,867 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Fifty Four [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 63,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.08 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 789,227 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Fifty Six [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 2,078 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 429,806 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Fifty Seven [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,178 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 402,121 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Fifty Eight [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 25,200 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 2,162 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 434,311 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Fifty Nine [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 25,200 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,372 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 398,854 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Sixty [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 40,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 4,581 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 630,384 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Sixty One [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,233 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.08 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 345,396 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Sixty Two [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 7,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 875 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 116,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Sixty Three [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,793 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 353,259 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Sixty Four [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 40,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 2,130 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 492,407 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Sixty Five [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 22,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 2,650 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.08 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 314,571 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Sixty Six [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,276 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 285,962 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Sixty Seven [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 40,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 4,986 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.08 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 571,977 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Sixty Eight [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,173 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | $ 0.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 351,782 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Sixty Nine [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 60,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 4,027 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 1,011,480 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Seventy [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 40,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 5,012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 760,980 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Seventy One [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 28,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,375 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 493,526 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Seventy Two [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 27,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,343 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 507,945 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Seventy Three [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 50,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 3,444 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 989,712 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Seventy Four [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 60,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 7,906 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 1,173,828 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Seventy Five [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,756 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 495,473 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Seventy Six [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 28,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,442 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 527,637 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Seventy Seven [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 50,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 2,089 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 964,609 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Seventy Eight [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 27,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,450 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 504,251 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued Seventy Nine [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt principal balance | $ 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt interest amount | $ 1,320 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion per share | $ 0.07 | $ 0.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt conversion shares | 296,111 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Per Hour [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consulting fee | $ 950 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Maximum [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consulting fee | $ 71,250 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of restricted shares issued | 750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Third Party [Member] | Consulting Services [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consulting expenses | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of common shares issued for services, value | $ 30,000 | $ 9,844 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of common shares issued for services | 234,375 | 7,500 | 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss on settlement of debt | $ 2,813 | $ 68,438 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share issued price per share | $ 0.14 | $ 0.42 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Third Party [Member] | Consulting Services [Member] | August 1, 2017 through January 31, 2018 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of common shares issued for services, value | $ 30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of common shares issued for services | 234,375 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of restricted shares issued | 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series A Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, shares authorized | 1,500,000 | 1,500,000 | 1,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, par value | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, shares designated | 1,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, shares issued | 500,000 | 500,000 | 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, shares outstanding | 500,000 | 500,000 | 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series B Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, shares authorized | 5 | 5 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, par value | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, shares designated | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, shares issued | 1 | 1 | 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, shares outstanding | 1 | 1 | 1 |
Commitments and Contingencies31
Commitments and Contingencies (Details Narrative) | Feb. 23, 2018 | May 04, 2016AUD ($) | Nov. 30, 2009 | Mar. 31, 2018USD ($) | Mar. 31, 2017USD ($) | Jun. 30, 2017USD ($) | Aug. 12, 2016USD ($) |
Penalty amount | $ 30,000 | ||||||
Rent expense | $ 23,734 | $ 22,237 | |||||
Royalty Agreement Terms [Member] | |||||||
Operating leases income statement revenue percentage | 2.00% | ||||||
License Agreement Terms [Member] | |||||||
Operating leases income statement revenue percentage | 5.00% | ||||||
Quality Assurance Agreement [Member] | |||||||
Contract cost | $ 1,557,739 | ||||||
Quality Assurance Agreement [Member] | Minimum [Member] | |||||||
Anticipated payment | $ 2,500,000 | ||||||
Quality Assurance Agreement [Member] | Maximum [Member] | |||||||
Anticipated payment | $ 5,000,000 | ||||||
Investment Banking Agreement [Member] | |||||||
Investment banker, description | As consideration for such services, the Company shall pay the Investment Banker 8% of the total gross proceeds immediately upon closing a successful capital raise placement. Additionally, the Company shall also pay the Investment Banker non-callable warrants for shares of the Companys common stock equal to 4% of the proceeds raised. The warrants will have a purchase price equal to 110% of the implied price per share of the placement or 110% of the public market closing price of the Companys common stock on the date of placement, whichever is lower, and will have an exercise period of five years after the closing of the placement. | ||||||
IRS [Member] | |||||||
Penalty amount | $ 10,000 | ||||||
Australia Dollar [Member] | New Five-Year Operating Lease Agreement [Member] | |||||||
Payments for fees | $ 3,300 |
Commitments and Contingencies -
Commitments and Contingencies - Schedule of Future Minimum Rental Payments for Operating Leases (Details) | Mar. 31, 2018USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
Remainder 2,018 | $ 7,613 |
2,019 | 30,452 |
2,020 | 30,452 |
2,021 | $ 25,377 |
Related Party Transactions (Det
Related Party Transactions (Details Narrative) | Mar. 16, 2018AUD ($) | Feb. 02, 2018USD ($) | Aug. 15, 2016USD ($) | May 05, 2016USD ($) | May 05, 2016AUD ($) | Feb. 25, 2016USD ($) | Feb. 25, 2016AUD ($) | Mar. 31, 2018USD ($) | Jun. 30, 2017USD ($) | Mar. 31, 2018AUD ($) |
Loans from related party | $ 56,906 | $ 56,802 | ||||||||
Due to related parties | 34,192 | 35,204 | ||||||||
Related party transaction, amount | 50,000 | |||||||||
Bonus | 183,260 | |||||||||
North Horizon Pty Ltd [Member] | ||||||||||
Lease term | 5 years | 5 years | ||||||||
Goods and service tax | $ 3,600 | |||||||||
North Horizon Pty Ltd [Member] | Australia Dollar [Member] | ||||||||||
Annual rental payments | $ 39,600 | |||||||||
Future minimum payments due | $ 122,100 | |||||||||
Current and Former Director [Member] | ||||||||||
Loans from related party | 56,906 | 56,802 | ||||||||
Two Current Directors [Member] | ||||||||||
Due to related parties | 34,192 | 35,204 | ||||||||
Nathanielsz [Member] | North Horizon Pty Ltd [Member] | Australia Dollar [Member] | ||||||||||
Future minimum payments due | $ 198,000 | |||||||||
Sylvia Nathanielsz [Member] | Through January 31, 2018 | ||||||||||
Compensation | 57,675 | |||||||||
Mrs. Nathanielsz [Member] | ||||||||||
Compensation | $ 92,280 | |||||||||
James Nathanielsz [Member] | ||||||||||
Payments for other fees | 31,518 | |||||||||
James Nathanielsz [Member] | Chief Executive Officer [Member] | ||||||||||
Payments for other fees | $ 120,000 | $ 130,000 | ||||||||
Officers' compensation | $ 250,000 | |||||||||
James Nathanielsz [Member] | Australia Dollar [Member] | ||||||||||
Related party transaction, amount | $ 4,481 | |||||||||
James Nathanielsz [Member] | Australia Dollar [Member] | Board of Directors [Member] | ||||||||||
Bonus | $ 300,000 | |||||||||
James Nathanielsz [Member] | USD [Member] | ||||||||||
Related party transaction, amount | $ 3,502 |
Concentrations and Risks (Detai
Concentrations and Risks (Details Narrative) | 9 Months Ended | 12 Months Ended |
Mar. 31, 2018 | Jun. 30, 2017 | |
Risks and Uncertainties [Abstract] | ||
Reimbursement on goods and service tax receivable percentage | 100.00% | 100.00% |
Derivative Financial Instrume35
Derivative Financial Instruments and Fair Value Measurements (Details Narrative) | Mar. 31, 2018USD ($)$ / sharesshares |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Warrant outstanding | shares | 12,000 |
Convertible debt | $ | $ 516,000 |
Share price | $ / shares | $ 0.10 |
Derivative Financial Instrume36
Derivative Financial Instruments and Fair Value Measurements - Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Details) | 3 Months Ended | 9 Months Ended |
Mar. 31, 2018 | Mar. 31, 2018 | |
Warrants [Member] | ||
Volatility | 246.60% | |
Expected remaining term (in years) | 6 months | |
Risk-free interest rate | 1.93% | |
Expected dividend yield | 0.00% | |
Convertible Debt [Member] | ||
Expected dividend yield | 0.00% | |
Convertible Debt [Member] | Minimum [Member] | ||
Volatility | 167.81% | |
Expected remaining term (in years) | 11 months 4 days | |
Risk-free interest rate | 1.87% | |
Convertible Debt [Member] | Maximum [Member] | ||
Volatility | 192.32% | |
Expected remaining term (in years) | 1 year 4 months 9 days | |
Risk-free interest rate | 2.09% | |
Convertible Debt [Member] | Initial Valuation [Member] | ||
Expected remaining term (in years) | 1 year | |
Expected dividend yield | 0.00% | |
Convertible Debt [Member] | Initial Valuation [Member] | Minimum [Member] | ||
Volatility | 195.25% | |
Risk-free interest rate | 1.79% | |
Convertible Debt [Member] | Initial Valuation [Member] | Maximum [Member] | ||
Volatility | 198.43% | |
Risk-free interest rate | 2.06% |
Derivative Financial Instrume37
Derivative Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($) | Mar. 31, 2018 | Jun. 30, 2017 |
Embedded conversion option liabilities | $ 555,166 | |
Total | 555,166 | $ 881,172 |
Fair Value, Inputs, Level 1 [Member] | ||
Embedded conversion option liabilities | ||
Total | ||
Fair Value, Inputs, Level 2 [Member] | ||
Embedded conversion option liabilities | ||
Total | ||
Fair Value, Inputs, Level 3 [Member] | ||
Embedded conversion option liabilities | 555,166 | |
Total | $ 555,166 |
Derivative Financial Instrume38
Derivative Financial Instruments and Fair Value Measurements - Schedule of Derivative Liabilities at Fair Value (Details) | 9 Months Ended |
Mar. 31, 2018USD ($) | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Balance at Beginning | $ 881,172 |
Effects of foreign currency exchange rate changes | 70 |
Reductions due to conversions | (658,772) |
Reductions due to repayment of debt | (199,339) |
Initial fair value of embedded conversion option derivative liability recorded as debt discount | 510,000 |
Initial fair value of embedded conversion option derivative liability recorded as change in fair value of embedded conversion option | 313,694 |
Change in fair value included in statements of operations | (291,659) |
Balance at Ending | $ 555,166 |
Subsequent Events (Details Narr
Subsequent Events (Details Narrative) - USD ($) | Apr. 30, 2018 | Apr. 26, 2018 | Apr. 18, 2018 | Apr. 13, 2018 | Apr. 12, 2018 | Apr. 11, 2018 | Apr. 05, 2018 | Apr. 03, 2018 | Apr. 02, 2018 | Mar. 31, 2018 | Mar. 31, 2017 |
Repayments of debt | $ 2,345 | ||||||||||
Subsequent Event [Member] | |||||||||||
Debt principal balance | $ 25,000 | $ 35,000 | $ 50,000 | $ 30,000 | $ 20,000 | $ 50,000 | $ 25,000 | $ 50,000 | |||
Debt interest amount | $ 526 | $ 3,259 | $ 3,750 | $ 1,289 | $ 929 | $ 2,256 | $ 1,386 | $ 2,916 | |||
Debt conversion per share | $ 0.04 | $ 0.04 | $ 0.03 | $ 0.04 | $ 0.04 | $ 0.05 | $ 0.05 | $ 0.06 | |||
Debt conversion shares | 686,183 | 1,062,747 | 1,560,232 | 841,095 | 581,358 | 1,088,658 | 506,649 | 912,659 | |||
Subsequent Event [Member] | April 13, 2018 Securities Purchase Agreement [Member] | |||||||||||
Convertible debt percentage | 8.00% | ||||||||||
Convertible promissory note, principal amount | $ 150,000 | ||||||||||
Subsequent Event [Member] | April 13, 2018 Securities Purchase Agreement [Member] | GS Capital [Member] | |||||||||||
Convertible debt percentage | 24.00% | ||||||||||
Subsequent Event [Member] | April 13, 2018 Securities Purchase Agreement [Member] | First Note [Member] | |||||||||||
Debt maturity date | Apr. 13, 2019 | ||||||||||
Common stock reserve | 7,684,000 | ||||||||||
Subsequent Event [Member] | April 13, 2018 Securities Purchase Agreement [Member] | April 2018 GS Capital Note [Member] | |||||||||||
Common stock trading volume, percent | 61.00% |